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Abstract
Epithelial-mesenchymal transition (EMT) regulates the cellular processes of migration,
growth, and proliferation - as well as the collective cellular process of tissue remodeling -
in response to mechanical and chemical stimuli in the cellular microenvironment. Cells of
the epithelium form cell-cell junctions with adjacent cells to function as a barrier between
the body and its environment. By distributing localized stress throughout the tissue,
this mechanical coupling between cells maintains tensional homeostasis in epithelial
tissue structures and provides positional information for regulating cellular processes.
Whereas in vitro and in vivo models fail to capture the complex interconnectedness
of EMT-associated signaling networks, previous computational models have succinctly
reproduced components of the EMT program. In this work, we have developed a
computational framework to evaluate the mechanochemical signaling dynamics of
EMT at the molecular, cellular, and tissue scale. First, we established a model of
cell-matrix and cell-cell feedback for predicting mechanical force distributions within
an epithelial monolayer. These findings suggest that tensional homeostasis is the result
of cytoskeletal stress distribution across cell-cell junctions, which organizes otherwise
migratory cells into a stable epithelial monolayer. However, differences in phenotype-
specific cell characteristics led to discrepancies in the experimental and computational
observations. To better understand the role of mechanical cell-cell feedback in regulating
EMT-dependent cellular processes, we introduce an EMT gene regulatory network of
key epithelial and mesenchymal markers, E-cadherin and N-cadherin, coupled to a
mechanically-sensitive intracellular signaling cascade. Together these signaling networks
integrate mechanical cell-cell feedback with EMT-associated gene regulation. Using this
approach, we demonstrate that the phenotype-specific properties collectively account
for discrepancies in the computational and experimental observations. Additionally,
mechanical cell-cell feedback suppresses the EMT program, which is reflected in the gene
expression of the heterogeneous cell population. Together, these findings advance our
understanding of the complex interplay in cell-cell and cell-matrix feedback during EMT
of both normal physiological processes as well as disease progression.
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Glossary
Name Abbreviation Description
Epithelial-mesenchymal
transition
EMT A reversible transition from the epithelial to mes-
enchymal phenotype indicated by a loss of cell-
cell junctions and apicobasal polarity with a corre-
sponding gain of front-back polarity and migratory
properties.
Transforming growth factor
β1
TGF-β A multifunctional growth factor that potently in-
duces epithelial-mesenchymal transition in an au-
tocrine and paracrine fashion.
Cellular Potts model CPM A lattice-based statistical model used to predict
cellular patterning by reducing cellular behavior
to its effective energy contribution.
Epithelial cadherin E-cadherin A calcium-dependent transmembrane protein that
forms the adherens junctions in cell-cell adhesion
of epithelial cells.
Neural cadherin N-cadherin A calcium-dependent cellular adhesion transmem-
brane protein expressed in mesenchymal cells un-
dergoing EMT.
Gene regulatory network GRN A signaling scheme including mRNA, miRNA, and
transcription factors which suppress or induce gene
transcription.
Extracellular matrix ECM The noncellular component of tissue which pro-
vides mechanical and chemical cues to guide cellu-
lar processes.
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Chapter 1
Introduction
Epithelial-mesenchymal transition (EMT) is a fundamental physiological process which
underlies a range of morphogenic processes in development, wound healing, fibrosis,
and cancer progression. Although the features and the molecular pathways of EMT
have been well documented, the underlying coordination between the extracellular and
intracellular signaling pathways that drive the EMT program and destabilize tissue
homeostasis remains unclear. This is largely due to the difficulty of experimentally
capturing the mechanical as well as chemical sequence of events that results in the spatial
and temporal progression of EMT.
The goal of this work is to elucidate the interplay of mechanical and chemical
signaling pathways in regulating the EMT program. In vitro and in vivo models, though
they characterize the molecular pathways involved in EMT, struggle to pin down the
interconnectedness of mechanical and chemical stimuli as a spatiotemporally evolving
program. EMT is a complex process that variably reacts to the heterogeneous signals
of the cellular microenvironment. Computational analysis provides distinct advantages
1
CHAPTER 1. INTRODUCTION
for examining the EMT program and identifying the sequence of events which produce
intermediate phenotypes. Though to definitively reproduce EMT in a computational
model, a multiscale approach is needed to capture the intracellular, intercellular, and
extracellular dynamics.
In Chapter 2, we provide an overview of EMT and the relevant mechanochemical
signaling networks that regulate it, emphasizing the role of feedback between the cell-
matrix and cell-cell junctions. In particular, we discuss the epithelial and mesenchymal
phenotypes of the EMT program, its key signaling networks, and the role of the
extracellular matrix composition. Chapter 2 concludes with a discussion of the relevant
computational models. Chapter 3 presents the computational framework of cellular
migration, with predictions of forces in an epithelial monolayer. We integrate this
computational framework with an intracellular signaling network in Chapter 4 that
captures gene expression throughout EMT. In Chapter 5, we discuss the relevance of
these findings as well as limitations and future directions.
2
Chapter 2
Literature Review
Sections of this dissertation chapter originally appeared in the literature
as
Scott LE, Lemmon CA, Weinberg SH. Mechanochemical signaling of the
extracellular matrix in epithelial-mesenchymal transition. Frontiers 2019.
doi: 10.3389/fcell.2019.00135
2.1 Introduction
EMT is a program of phenotype regulation in which epithelial cells undergo
transdifferentiation into mesenchymal cells. This is an essential process for cellular
organization and tissue morphogenesis during embryonic development, and it has also
been implicated in a wide array of pathological states. The phenotype states of EMT
emphasize a switch in motility machinery, reflected in the downregulation of adhesion
3
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between neighboring epithelial cells (cell-cell) and upregulation of adhesion to the
underlying extracellular matrix (cell-matrix).
The epithelium is characterized by polarized sheets of cells that form by self-
organization and reside in a mechanical equilibrium. Cells generate cytoskeletal tension
via actomyosin contractility, which is transferred to the underlying matrix by cell-matrix
attachments and to adjacent cells across cell-cell junctions. This tensional homeostasis
results in a cohesive tissue structure, and is essential to maintaining barrier and signaling
functions of the epithelial sheet.
This mechanical equilibrium relies on coordinated tissue scale dynamics extending
beyond local cell-cell and cell-matrix adhesions. Local perturbations to the equilibrium
state produce in localized stress in the monolayer and a disruption to the tensional
homeostasis. The constitutive mechanical interactions between the cell and its
environment are coupled to molecular signaling networks that regulate gene expression,
known as EMT-activating transcription factors (EMT-TFs). In turn, EMT drives
changes in the mechanics and composition of the ECM, creating a feedback loop that is
tightly regulated in healthy tissues, but is often dysregulated in disease. As such, spatial
patterning of mechanical stress can facilitate phenotypic regulation and is crucial to both
maintenance and disruption of tissue homeostasis.
4
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2.2 Epithelial-mesenchymal transition
In general, transdifferentiation from the epithelial to the mesenchymal phenotype
involves disruption of cell-cell junctions, loss of apicobasal polarity which gives the
epithelium its characteristic cobblestone morphology, and induction of cell migration.
Hallmarks of the mesenchymal phenotype include front-back polarity, independent
migration, and an elongated cell shape. The loss of epithelial characteristics often
corresponds with a gain of mesenchymal characteristics such that the transdifferentiation
process is both continuous and conserved. The EMT program, and its reverse process
mesenchymal-epithelial transition, underlies tissue morphogenesis of both physiological
processes from embryogenesis (type I) to wound healing (type II), and pathophysiological
processes such as fibrosis and metastasis (type III) (1). In Sections 2.2.1 and 2.2.2, we
provide further detail of the epithelial and mesenchymal phenotype, emphasizing their
interactions with the microenvironment.
2.2.1 Epithelium
The epithelium is the first to form during embryonic development, and from it the
mesenchyme develops to give rise to organ tissue structure (reviewed in (2)). The
epithelium is characterized by a polarized sheet-like structure with an apical and
basolateral domain that directs attachment to the basal lamina and adjacent cells.
Unique to metazoa is the presence of an extracellular matrix (ECM) to which the
epithelium and mesenchyme adhere. An adherent inner network of sheet-like matrices
known as the basal lamina, together with an outer fibrillar matrix known as the
connective tissue, stabilize the epithelial tissue architecture (further described in
5
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Section 2.4). The ECM provides both mechanical and chemical cues that mediate the
epithelial polarity program. Epithelial attachment to the basal lamina defines the basal
membrane, whereas the apical surface is freely exposed to the luminal space, giving
epithelium its apicobasal polarity (3; 4). Complete epithelial differentiation requires
assembly of the basal lamina and the cell adhesion receptors that link the extracellular
environment to intracellular signaling pathways (5).
Polarity complexes partition the cell-cell adhesion into an apical and basolateral.
Tight junctions at the apical cuticle and focal contacts at the basal membrane organize
the cytoskeleton into a subcortical belt, thereby stabilizing the cytoskeletal structure.
Structural filaments anchored at focal contacts between adjacent cells mechanically
couple the epithelium and stabilize the epithelial tissue architecture as a whole. The
apicobasal polarity also aligns polarized tubular structures, microtubules, for transport
to the apical and basolateral domains as well as proliferation along the planar axis (6).
The characteristic epithelial sheet-like structure stems from calcium-dependent
homophilic bonds between adherens ectodomains, ultimately forming cell-cell junctions
(7), which consist of adherens junctions, tight junctions, gap junctions, and desmosomes.
The adherens ectodomains stabilize lateral epithelial contacts through trans-cis biphasic
dimerization in which trans bonds initiate single pair attachments and cis bonds stabilize
multi-pair adhesions (8). The cytoplasmic domain of the adherens junction consists of
catenin complexes which couple cadherins to the cortical actin cytoskeleton (discussed
in Section 2.3.4), forming a belt-like structure. Through these cell-cell attachments,
the epithelium distributes biomechanical forces about the tissue to maintain a static
equilibrium.
6
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2.2.2 Mesenchyme
The mesenchyme derives from the epithelium by suppression of epithelial differentiation.
Transcriptional regulation of the EMT targets cell adhesion molecules of epithelial genes,
chiefly epithelial cadherin (E-cadherin) (9). Of particular importance is the disruption
of the apical membrane through destabilization of tight junctions (10). Redistribution
of polarity complexes away from the apical membrane disrupts the subcortical actin belt
and promotes cell-matrix attachment (11).
Transdifferentiation between the epithelial and mesenchymal phenotypes is context
dependent, requiring transduction of microenvironment cues by cell-cell and cell-matrix
adhesions into intracellular signaling cascades. Downstream targets of these pathways,
in turn, regulate cellular adhesions, polarity, cytoskeletal architecture, survival, and
proliferation. Microenvironment signals such as growth factor signaling (12), and
mechanical force (13) suppress epithelial differentiation by disrupting cell-cell adhesion,
cytoskeletal reorganization, and remodel the extracellular matrix (14). These same
pathways are characteristic of fibrosis, tumorigenesis, and metastasis (15; 16; 17; 18; 19).
In particular, aberrant extracellular matrix remodeling, which underlies the characteristic
tissue stiffening of fibrosis and cancer (20; 21), promotes cell-matrix adhesion and further
stimulates EMT (22; 23; 24).
In comparison to epithelial cells, mesenchymal cells favor front-back polarity,
cell-substrate adhesion, and a spindle-like morphology (25). Consequently, mesenchymal
cells exhibit migratory behavior and rapid ECM turnover to form tissue conducive to
migration. In the earliest occurrence of EMT during embryo development, the epiblast
epithelium recedes posteriorly to form the mesodermal primitive streak, which later gives
7
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rise to the neural crest as well as each distinct adult tissue (26). Hence, the earliest
function of EMT produces a mesenchymal phenotype capable of migrating away from
the epithelium while remaining loosely adhered to adjacent cells. Subsequent cycles of
EMT revert mesenchymal cells to epithelial cells for tissue maturation, which implies
reversibility of EMT (27).
8
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2.3 Mechanochemical signaling networks in epithelial-
mesenchymal transition
Interacting mechanical and chemical feedback loops form a signaling network
for regulation of the EMT program. At the cell-cell and cell-matrix interfaces,
mechanically-sensitive receptors, referred to as mechanoreceptors, transduce forces from
cellular interface adhesions to intracellular signaling pathways in a process known as
mechanotransduction (28). Typically, mechanical stimulation from these two sources are
inversely related such that a decrease in cell-cell adhesion corresponds to an increase
in cell-substrate adhesion (29). This is consistent with transcriptional regulation
corresponding to a downregulation in E-cadherin and upregulation of neural cadherin
(N-cadherin) observed in EMT. Both the mechanical forces at the cellular interfaces and
molecular signaling cascades, known together as mechanochemical stimuli, regulate the
EMT program, though the underlying coordination between the two remains unclear
(30; 31; 32; 33; 34). Elucidating the role of these complex, coordinated signaling
pathways in driving the EMT program is necessary for our understanding of morphogenic
processes, physiological and pathophysiological alike.
2.3.1 Molecular signaling cascades
An EMT-associated gene regulatory network (EMT-GRN) tightly regulates EMT
through molecular signaling cascades consisting of EMT-TFs and miRNAs (35; 36; 37),
which maintain tissue homeostasis of an epithelial monolayer by epigenetic control of
9
CHAPTER 2. LITERATURE REVIEW
epithelial and mesenchymal genes (38; 39; 40; 41). The result is a change in cellular
adhesions accompanied by ECM remodeling.
Micro RNAs (miRNA), 22 base pair nucleotides of non-coding RNA, repress
translation of target EMT-TFs mRNAs by binding to target genes at miRNA recognition
elements. Together, miRNAs and EMT-TFs form a network of negative feedback loops
that cooperatively control the switch between epithelial and mesenchymal phenotypes
(9). This transcriptional regulation scheme permits biphasic mobility states with
potential for phenotype reversion (42).
Signaling molecules, commonly Wnt and transforming growth factor β 1 (TGF-β),
and ECM proteins activate EMT-TFs, primarily the zinc finger protein SNAIL1 and
basic helix loop helix zinc finger E-box-binding homeobox (ZEB), that bind E-box
promoters of cell adhesion molecules, particularly the E-cadherin gene cadherin-1
(CDH1) (41), and polarity proteins to repress transcription (43; 44; 45; 46).
TGF-β is a potent inducer of EMT by two signaling mechanisms: the canonical
SMAD pathway and the non-canonical phosphatidylinositol 3-kinase (PI3K)/Akt
signaling pathway (47). Both pathways favor cell migration by transcriptional
suppression of E-cadherin thereby reducing cell-cell adhesion, increasing cell-substrate
adhesion, and upregulating N-cadherin (48; 49; 50). In addition to repressing cell-cell
adhesion, TGF-β also induces expression of proteins associated with ECM remodeling
(51) as well as cell contractility through the Rho-ROCK pathway, which is necessary for
migration and ECM assembly.
Wnt targets transcriptional regulation of the epithelial phenotype by preventing
uniquitination of β-catenin by GSK3β for proteasomal degradation (52). As a result,
10
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stabilized β-catenin accumulates in the cytoplasm, colocalizes with transcription factors
TCF/LEF, and translocates to the nucleus where it recruits co-activators for gene
transcription (53). The N-terminal domain of β-catenin also interacts with SNAIL1 as
a transcriptional co-regulator of EMT, though the mechanism of transcription requires
further investigation (54). Aberrant Wnt/β-catenin signaling has been identified for its
role in tumorigenic and metastatic potential in the garden-variety of cancers (55; 56).
The canonical Wnt/β pathway stabilizes nuclear localization of EMT-TFs SNAIL1 and
SNAIL2 to initiate EMT. (57).
Which signaling scheme takes precedence in driving EMT is uncertain. Disruption
of cell-cell junctions releases β-catenin for nuclear localization, although GSK3β
phosphorylates β-catenin for degradation in the absence of one of the EMT-associated
signaling pathways (44). Alternatively, cell-matrix mechanical feedback stimulates
secretion of TGF-β, which are sequestered into the ECM and concentrated at the cell
surface to act as an EMT feedforward loop for adjacent cells (58). In fact, inhibiting
ECM assembly potentially blockades EMT progression altogether (59; 60). Hence,
EMT is in need of further elucidation to unravel the interplay between biochemical and
biomechanical signaling.
2.3.2 EMT-associated gene regulatory network
Disruption of the E-cadherin junctions, nuclear translocation of β-catenin, and repression
of the CDH1 gene by the key transcription factors SNAIL1, TWIST, and ZEB are all
initiating events of EMT. EMT homeostasis is achieved by negative feedback loops
between CDH1 repressors, SNAIL1 and ZEB, and CDH1 protectors, miR-200 and
11
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miR-34 (36; 37). By upregulating mRNA SNAIL1, exogenous TGF-β, acting through the
canonical SMAD signaling pathway, destabilizes the GRN in favor of the mesenchymal
phenotype(30; 31).
2.3.3 Mechanotransduction
Mechanical feedback between the cell and its environment is coupled to molecular
signaling pathways that regulate gene expression. The epithelial cell-cell junctions
mechanically couple adjacent cells and redistribute anisotropic stress throughout the
monolayer (32). As a result, the epithelium acts as a cohesive structure, which allows
for coordinated dynamics at the tissue scale. However, mesenchymal cells downregulate
the proteins associated with cell-cell adhesion in favor of cell-matrix attachments and
migration.
Integrin receptors primarily facilitate cytoskeletal coupling and downstream signaling
for cell-matrix attachments. Crosstalk between the downstream cell-cell and cell-matrix
adhesion signaling pathways further amplifies transcriptional regulation of the EMT
program (34), discussed further in Section 2.3.4.
2.3.4 Cell-matrix and cell-cell adhesion
Integrin receptors not only relay mechanical feedback by transcriptional regulation but
also through crosstalk with mechanoreceptors at the cell-cell interface (61). Integrin
binding destabilizes the adherens junction through focal adhesion kinase (FAK)/Src
signaling and actomyosin contractility, resulting in E-cadherin endocytosis (62; 63; 64).
12
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The E-cadherin ectodomain forms trans and cis homodimeric bonds with E-cadherin
on both the same cell and adjacent cell (65), and the cytoplasmic domain colocalizes with
a catenin complex - β-catenin, α-catenin, and p120 - to bind to the actin cytoskeleton
(66). The nascent cell-cell junctions are punctate attachments consisting of the
scaffolding protein nectin, an immunoglobulin-like calcium independent cell-cell adhesion
protein. Through Rho GTPase-mediated cytoskeletal rearrangement and E-cadherin
recruitment, nectin facilitates maturation of nascent punctate adhesions into a compacted
adherens junction, which provides a scaffold for the assembly of a subcortical actomyosin
contractile belt (67). Subsequent Rho/ROCK stimulates apical membrane contraction,
compacting the punctate E-cadherin dimers into a mature adherens junction (68). This
compaction process additionally recruits Rac for downstream PI3K activation of Akt,
which in turn recruits paxillin to the E-cadherin junctions by an mTor/PKCα/RhoA
signaling cascade and stabilizes the cytoskeleton-to-adherens junction (69).
2.3.5 Mechanotransduction of cell-cell junctions
Disruption of the adherens junction during EMT releases components of the cadherin
complex to translocate to the nucleus and further downregulate E-cadherin expression
(66; 70). In particular, β-catenin cooperatively acts with transcriptional factors ZEB,
TWIST, and SNAIL1 to repress the E-cadherin gene, CDH1. Furthermore, cytoskeletal
stress, which is no longer distributed across the adherens junction to neighboring cells,
transfers to cell-matrix attachments (71). In response, the epithelial and mesenchymal
genes orchestrate transdifferentiation through a spectrum of partial EMT phenotypes,
each having a distinct propensity for cell-cell and cell-matrix adhesion. The end result
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of the mesenchymal phenotype is a cadherin-type switch from E- to N-cadherin, which
promotes cellular migration through lamellipodial and filopodial outgrowth (72; 73; 74).
Yet, the extent to which disruption of cell-cell junctions drives the EMT program is
unclear.
2.3.6 Mechanotransduction in disease
Healthy adult tissue has an optimal stiffness sensed by cell adhesion molecules that
transduce mechanical feedback from the microenvironment to intracellular signaling
pathways (75). These cell adhesion molecules that transduce mechanical feedback also
stimulate cytoskeletal reorganization through associated mechanosensing cytoskeletal-
linked proteins such as vinculin and talin (76). Tissue stiffness has been identified as
a marker for a number of diseases (77). In particular, identification of tissue stiffening
as a marker of cancer progression and a precursor to metastasis (78) illustrates the
importance of the mechanical mechanisms underlying EMT as potential targets for novel
therapies (79).
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2.4 Cell-matrix mechanochemical feedback
A downstream effect of EMT is ECM remodeling from an epithelial ECM to a fibrous
ECM. Epithelial tissue, consisting of a thin, dense specialized ECM known as the
basement membrane, provides a structural scaffolding at the basal membrane for
epithelium attachment (80). Feedback at these cell-matrix attachments establishes the
apicobasal axis and stabilizes the monolayer (81). Typically, the epithelium exhibits
normal physiological function when in contact with the basement membrane, but not
when exposed to fibrillar matrix components.
Unlike the basement membrane, mesenchymal ECM is fibrous and crudely aligned.
Although connective tissue lacks inherent organization, cell traction forces pull the fibers
into alignment parallel to the direction of applied force. This is of particular interest
when exploring mechanical response of the extracellular matrix, and the reciprocal
mechanical regulation of cellular processes.
2.4.1 Basal lamina and epithelial-mesenchymal transition
Nidogen and perlecan bridge the innermost cell-adherent layers of the basement
membrane, the laminin-rich lamina lucida and collagen IV-rich lamina densa, to form
a supramolecular, reticular structure known as the basal lamina (82). Cytoskeletal
recruitment, stimulated by cell adhesion to the basal lamina, strengthens focal contacts
and reinforces the epithelial tissue architecture. Developmental studies indicate that
laminin not only maintains epithelial differentiation but is also the progenitor of the
basement membrane and epithelial polarization during gastrulation (reviewed in (83)),
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suggesting laminin contributes to epithelial differentiation rather than mesenchymal
suppression (84; 85).
Laminins self-assemble into a sheet-like matrix at the cell surface and mediate cell
attachment to integrin, dystroglycan, sulfated glycolipids, and heparan sulfate chains
(86). The laminin-specific integrin receptor α3β1 localizes to the cytoplasmic plaque of
cell-cell junctions, where it forms a complex with α-actinin and links the subcortical
actin network to the catenin complex of cell-cell junctions (87), contributing to the
integrity of the epithelium by reinforcing cell-cell junctions. Integrin α6β4 is localized to
a multiprotein complex known as the hemidesmosome, which anchors the cytoskeleton to
the basal lamina, provides attachment for intermediate filaments, and further stabilizes
the epithelium (88).
Despite its role in maintaining epithelial differentiation, elements of the basal
lamina can also promote EMT. For example, laminin receptors α3β1 and α6β4 have been
implicated in EMT and cancer progression in which integrin ligation was sufficient for
tumor formation (89). Integrin-linked downstream signaling pathways were shown to
activate EMT-associated FAK, Rac1, MAPK, and JNK pathways(90).
Studies of alveolar epithelium(91; 92) and hepatocellular carcinoma(93) demonstrate
cooperative activity between α3β1 and transforming growth factor β1 (TGF-β) to suppress
the epithelial phenotype. Colocalization and endocytosis of α3β1 with the TGF-β receptor
type I (TGFβRI) receptor led to formation of a pSmad2-β-catenin transcription complex,
though it is unclear how this complex suppresses the epithelial phenotype. A separate
study in immortalized mouse keratinocytes demonstrated that α3β1-TGF-β cooperativity
induces tissue remodeling of the basal lamina (94; 95) and induces epithelial EMT-TFs,
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SNAIL1 and SNAIL2 (64). Hepatocellular carcinomas overexpressing α6β4 exhibit
aberrant cell proliferation and invasion associated with downregulation of the epithelial
phenotype by PI3K/Akt signaling dependent upregulation of SNAIL2 (96).
2.4.2 Fibrous matrix and epithelial-mesenchymal transition
Assembly of fibrillar matrix on the basement membrane plays a significant role in
repressing the epithelial phenotype and inducing EMT. Fibronectin, a 230-270 kDa
fibrous glycoprotein that provides a scaffold for cell attachment (97), is secreted as a
soluble dimer and requires integrin attachment and cell contractility for polymerization
into an insoluble fibrillar matrix (98; 99). Integrin binding facilitates fibronectin stretch,
which exposes additional binding sites for ECM deposition and growth factor binding
(100). Primarily integrins α5β1 and αvβ3 dynamically bind to the fibronectin matrix to
extend pseudopodia and form contractile filaments via small GTPases (101).
Dysregulation of fibrillar matrix is widely implicated in fibrosis(102) and cancer
progression (103; 104; 105), owing to the suppression of epithelial differentiation (106).
As a downstream target of Wnt (107) and TGF-β(108) signaling, fibronectin is a marker
of mesenchymal differentiation (109). Fibronectin accumulation at cleft-forming sites
during salivary gland and lung branching morphogenesis induces SNAIL2 to suppress
the epithelial phenotype (110).
Fibrillar collagens, acting through canonical β1 integrin/FAK/Src signaling, suppress
epithelial differentiation at the transcriptional level and disrupt the cadherin complex to
enhance cell mobility (reviewed in (111)). In ovarian and prostate cancer cells, collagen-β1
binding alters E-cadherin expression through both PI3K- (112) and Src-dependent
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mechanisms (113). Collagen I promotes Snail and LEF1 through ILK-dependent
activation of NF-κB and inhibition of GSK3β, which drives transcriptional activation of
SNAIL1 (114). In a separate study of pancreatic carcinoma cells, DDR1 and β integrin
concomitant activation converges on JNK signaling to increase expression of N-cadherin,
a mesenchymal marker of EMT (115).
Given its role in maintaining adherens junctions, collagen-DDR signaling may
indicate a switch from cell-cell to cell-matrix adhesion. Switching from epithelial-
associated to mesenchymal-associated DDR drives mesenchymal differentiation by
activating and stabilizing EMT transcription factors SNAIL1 and ZEB, and by inducing
gelatinases to promote invasion (reviewed in (116)). Collagen I-DDR2 ligation induces
invasion of metastatic mammary epithelium in vivo and in vitro by activating Src/ERK
signaling to induce SNAIL1 (117). Similarly, TGF-β-induced DDR2 expression in
human renal proximal tube epithelial cells suppresses the epithelial phenotype via
NF-κB and LEF-1 activation (118). These studies indicate that fibrillar collagens, and
also other collagenous ECM (119; 120; 121; 122), are active EMT through downstream
transcriptional suppression of the epithelial phenotype as well as disruption of cell-cell
junctions.
2.4.3 Connective tissue and growth factor tethering.
Just as in the basal lamina, proteoglycans of connective tissue sequester soluble factors
as a means to regulate bioavailability or to spatially confine activation. Neighboring the
primary cell attachment domain of fibronectin, a growth factor binding domain localizes
growth factor signaling near the cell attachment for simultaneous activation of signaling
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pathways that promote survival and migration(123). One example of this in EMT is the
latent TGF-β-binding protein (LTBP), which binds to fibronectin at the type III12−14
repeat and sequesters TGF-β in a conformationally latent form until mechanically or
proteolytically activated (124; 125). Confining TGF-β to the ECM in this latent form
allows for spatial and temporal control over TGF-β activation (126). In the ECM-bound
latent form, TGF-β is activated through cell contractility or proteolytic cleavage. The αv
integrins, namely αvβ6 and αvβ8, bind to the RGD sequences in fibronectin and latent
TGF-β complex LAP to conformationally alter LAP and activate TGF-β (127).
Taken together, conventional integrin signaling and growth factor availability
regulation represent two distinct but interacting mechanisms by which fibrillar ECM
regulates EMT (128). Previous studies of mammary breast epithelium suggest
fibronectin, but not laminin, is necessary for TGF-β-induced EMT, likely due to binding
the fibronectin receptor α5β1 integrin and latent TGF-β localization (59; 60). Fibronectin
receptor αvβ3 integrin has also been shown to phosphorylate TGFβRII at Y284 to
activate p38/MAPK signaling, separately from canonical Smad signaling, and promote
tumor invasion (129).
2.4.4 Tissue remodeling and epithelial-mesenchymal transition
Tissue remodeling in development (130) and tissue repair (131; 132) requires fine
spatiotemporal control over ECM degradation, which is often dysregulated in fibrosis
(133; 134; 135) and cancer progression (136; 137; 138; 139). Through proteolysis of the
ECM and its sequestered latent signals, MMPs modify the molecular and mechanical
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characteristics of the extracellular microenvironment to facilitate cellular migration
(140).
Beyond the structural effects on ECM, MMP proteolytic processing of the basal
lamina produces bioactive fragments (141), many of which regulate angiogenesis (142)
and migration (143) in a paracrine fashion. For example, collagen IV fragment α5 binds
collagen receptor DDR1, preventing distribution to cell-cell junctions, and activates
ERK (144), a downstream signal of TGF-β-induced EMT (49; 145), and a laminin-111
β-chain fragment competitively binds α3β1 integrin to upregulate mesenchymal markers
and switch gelatinase A (MMP2) production in the inner lamina lucida to gelatinase B
(MMP9) in the outer lamina densa and reticular lamina.
Additionally, MMPs dock with cell adhesion receptors, facilitating proteolytic
activation of latent signaling molecules sequestered within the ECM and inducing
survival and migratory signaling pathways (146; 147; 148). Gelatinases (149),
stromelysin (MMP3) (150), and membrane type (MT)-MMPs (151) each proteolytically
activate latent form of TGF-β, which subsequently upregulates gelatinases thereby
creating a self-sustaining loop of matrix remodeling (152).
One last mechanism by which tissue remodeling drives EMT is by MMP-mediated
receptor shedding. MT-MMP (153), MMP3 (154), MMP9, and matrilysin (MMP7)
(155) localize at the adherens junctions to shed the E-cadherin ectodomain, producing a
soluble fragment frequently increased in the serum of cancer patients (156). The 80 kDa
ectodomain fragment acts as a paracrine/autocrine signal that reduces cell aggregation
by competitive homophilic binding with E-cadherin (157) and promotes MMP production
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via EGFR (158). MMP3 additionally cleaves E-cadherin, which specifically activates
Rac1 splice variant Rac1b that in turn activates the EMT-TF SNAIL (159).
2.4.5 Cell-matrix mechanical feedback and epithelial-
mesenchymal transition.
In addition to the compositional aspects of ECM-EMT regulation, mechanical feedback
at cell-matrix interfaces is an important regulator of EMT (160). Mechanical coupling
between a cell and its environment allows for rapid signal transduction and propagation
across the tissue. The cell adhesion receptors and focal adhesion proteins which tranduce
ECM feedback to intracellular signaling cascades, reorient the cytoskeleton to mitigate
anisotropic tension (161). Prior studies have demonstrated that induction of EMT is
dependent on the mechanical properties of the underlying tissue; in vitro, TGF-β induces
EMT on surfaces with a high elastic modulus yet induces apoptosis on surfaces with a
lower elastic modulus (23). Inherent tension within a tissue also induces EMT; areas of
higher stress within a colony of epithelial cells correlates with EMT, while ares of lower
stress maintain the epithelial phenotype (162).
Deposition and organization of the ECM is sensitive to substrate stiffness (163) such
as in the case of fibronectin assembly (164). A proposed mechanism suggests that stretch
of fibronectin type III repeats exposes additional growth factor and ECM binding sites
that promotes further ECM deposition (99). This interplay between substrate stiffness
and ECM remodeling facilitates excessive matrix deposition and further stiffening of the
ECM (165).
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In addition to matrix deposition, the effects of matrix stiffening may enhance
signaling of tethered growth factors. In alveolar epithelial cells, fibronectin facilitates
stiffness-dependent EMT induced by TGF-β. The requirement for integrin αv that binds
both fibronectin and the TGF-β complex suggests cell contractility mediates the substrate
stiffness response to TGF-β-induced EMT (166). The αv integrin activates latent TGF-β,
which in turn induces LOX-mediated ECM crosslinking of collagen and ECM stiffening
(167; 168). In NMuMG cells, matrix rigidity regulates the switch from TGF-β–induced
apoptosis and to EMT via a FAK/PI3K/Akt signaling cascade (23). These studies
indicate integrin receptors mediate the activation of fibronectin-TGF-β-induced EMT in
a contractility-dependent manner.
Although mechanical feedback drives rearrangement of cytoskeletal components to
induce EMT (reviewed in (169)), it also facilitates actin recruitment to reinforce adherens
junctions on stiff substrates (170). Tensile forces unfolds α-catenin to reveal cryptic
vinculin-binding sites, which nucleate polymerization of actin microfilaments (171). The
exact sequence of events regulating this switch are unclear.
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2.5 Computational models of molecular, cellular,
and tissue scale phenomena
2.5.1 Cellular Potts model
The CPM, deriving from the statistical mechanics large-q Potts model, is a two-
dimensional square lattice model, which applies thermodynamic constraints as a general
basis for cell sorting and is often useful for predicting cell migration (172; 173). These
thermodynamic constraints are described by an energy function, the Hamiltonian,
that summarizes cellular phenomena as a contributor to probabilistic behavior. The
Hamiltonian is expressed as a function of contact costs between neighboring lattice sites.
By delineating the energy contribution of cellular phenomena to the net energy of the
cell, both simple and complex cellular processes are therefore translated into succinct
thermodynamic terms for simulation.
Van Oers and colleagues, in particular, apply the CPM to predict formation of
vascular structures resulting from cell-matrix mechanical feedback (174). To simulate
cell-matrix feedback the CPM cells additionally occupy a finite element mesh, which
simulated cell traction forces deflect to produce substrate strain. Resulting substrate
strains reduce the net energy cost of cellular extension, which emulate filopodial and
lamellipodial extensions, into neighboring lattice domains. Similar studies have applied
the CPM to describe the role of cell-cell and cell-matrix feedback in regulating EMT
(175) and cardiac cushion morphogenesis (176).
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2.5.2 Cellular Potts model and extracellular matrix remodeling
Daub & Merks (177) also have applied the CPM to determine the relative effects of
chemotaxis, haptotaxis, and ECM remodeling on endothelial sprouting. However, in
comparison to the van Oers approach, the lattice sites not occupied by cells contain dense
ECM, which restricts cell movement at the migratory front. Membrane-bound matrix
metalloproteinases (MMP), a group of enzymes that break down ECM, locally digest
the ECM and cells consequently migrate towards favorable regions of ECM density, i.e.
haptotaxis.
2.5.3 Epithelial-mesenchymal transition gene regulatory
network
Previous in vitro work has identified a TGF-β-sensitive gene regulatory network of EMT
through master transcriptional regulators SNAIL1 and ZEB with miR-34 and miR-200
counterparts (178; 179; 180). Tian and colleagues proposed a dynamical system of
cascading bistable switches (CBS), which consists of two double negative feedback loops
that regulate this EMT-GRN (181) (further described in Chapter 4). The CBS model
predicts the stability of phenotype states - i.e. epithelial, intermediate, and mesenchymal
- during EMT when exposed to exogenous TGF-β. This study reveals a latent partial
mesenchymal phenotype capable of reversion to the epithelial phenotype, which is
consistent with in vitro observations (27; 182; 183; 184). Zhang et al. (42) subsequently
validated these predictions in vitro and revise the CBS model to account for additional
configurations of mRNA-miRNA complexes.
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2.5.4 Mechanotransduction at the adherens junction
For mechanotransduction at cell-cell junctions, β-catenin provides a reasonable
approximation to the cell bound/unbound state as it is either localized at the cell-cell
junctions or in the nucleus. Ramis-Conde and colleagues (185) developed a dynamical
system of β-catenin localization within the cell dependent on the cell bound/unbound
state. This model predicts the mobility of cells within a monolayer from β-catenin
concentration, and suggests β-catenin nuclear translocation is a sufficient perturbation
to cell-cell adhesion for EMT-like events to occur.
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2.6 Summary
Our understanding of the EMT program has advanced from its first description as two
distinct phenotype states to a spectrum of partial phenotypes sensitive to mechanical and
chemical cues. Together, the mechanochemical signaling pathways form a coordinated
regulatory network converging on a small number of epithelial and mesenchymal genes.
Figure 2.1 shows an overview of the relevant mechanochemical signaling pathways
considered for this work. First, E-cadherin junctions form the main adhesion between
adjacent cells and distribute the junction force across cell-cell contacts (Step 1).
E-cadherin further regulates β-catenin signaling, which is either localized at the cell-cell
adhesion, destroyed by the proteasome, or localized in the nucleus (Step 2). As a
transcriptional regulator, β-catenin suppresses CDH1 and reduces available E-cadherin
as a result (Step 3). The EMT-GRN is also regulated by TGF-β signaling (Step 4), which
additionally suppresses E-cadherin and upregulates ECM production and remodeling
(Step 5).
In this work, we develop a multiscale computational framework of the mechanochem-
ical regulation of the EMT program (Fig. 2.2). In Chapter 3, we begin with the
CPM-FEM to evaluate the effect of cell-matrix mechanical feedback on general cell
organization and predict traction and junction forces within an epithelial monolayer
(Fig. 2.2, blue blocks). We introduce cell proliferation and determine the connectivity of
adjacent cells, which is then used for evaluating the traction forces of the multicellular
cluster from the FMA model. The junction force predictions are then implemented
in Chapter 4 to determine the bound/unbound state of adjacent cells for mechanical
regulation of the EMT-GRN (Fig. 2.2, red block). The gene expression is tracked for
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Figure 2.1. Overview of the mechanochemical signaling framework discussed in this
work.
each cell throughout the simulation, from which we estimate the phenotype of each
cell. A comprehensive parameter analysis additionally identified particular combinations
of contact energies for approximating TGF-β-dependent effects on cell mobility for
implementation in Chapter 4, Section 4.3.4. The phenotype then sets CPM cell properties
defined for a continuum of EMT states, from epithelial to mesenchymal.
An additional output of the EMT-GRN is the mesenchymal marker, fibronectin. Cell
traction forces assemble fibronectin fibrils while fibronectin fibrils facilitate cell-matrix
attachment (164). Using the traction forces predicted by the FMA model together with
production of ECM, we can predict ECM remodeling downstream of the EMT program
(Fig. 2.2, yellow block). The traction forces subsequently assemble fibronectin fibrils
which facilitate cell-matrix attachment, reflected in the force-distance scaling factor
used in the FMA (Chapter 3, Section 3.2.3). In turn, this ECM remodeling alters the
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mechanical properties of the finite element mesh and cell-matrix contact penalty as
described by Daub & Merks (177). We anticipate that fibronectin fibrillogenesis, together
with TGF-β stimulation, will drive a spatially localized positive feedback loop sufficient
to induce EMT. We leave the EMT-dependent regulation of the ECM for future work.
Figure 2.2. The computational framework described in this work consists of
subsystems intended to predict the dynamics at the molecular, cellular, and organ scale.
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Mechanical cell-cell feedback of the
epithelial monolayer
This chapter is currently available in preprint as
Scott LE, Griggs LA, Narayanan V, Conway DE, Lemmon CA, Weinberg
SH. A Predictive Model of Intercellular Tension and Cell-Matrix Mechanical
Interactions in a Multicellular Geometry. bioRxiv. 2019. doi: 10.1101/701037
3.1 Introduction
In Chapter 3, we explore the role of cellular adhesion in maintaining tensional
homeostasis of epithelial monolayers. Previously, van Oers and colleagues developed a
CPM coupled with a finite element model (FEM) to examine the role of mechanical
feedback of the extracellular matrix in guiding cellular migration and alignment (174).
To simulate epithelial monolayers, we extend the CPM-FEM capabilities of simulating
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individual cellular traction forces to predict junctional forces in a multicellular cluster.
Traction forces are determined from the first moment of area (FMA) about the single
cell geometry, as previously modeled and validated by Lemmon & Romer (186). The
FMA model approximates cellular traction forces at discrete points within the individual
cell geometry with magnitude proportional to the distance from and direction oriented
towards the cell centroid. These traction forces generate substrate strains which, in
addition to cell-cell and cell-matrix interactions, impose a thermodynamic constraint
and govern the dynamics of individual cells in the CPM.
First, we incorporate the formation of cell-cell adhesion between neighboring cells
to accurately represent the biology of epithelial cells. Next, we extend the FMA model
to multicellular clusters, and model traction forces based on the multicellular geometry
rather than the single cell geometry. As a result, individual cell traction forces are
proportional in magnitude to the distance from the centroid of the multicellular cluster,
rather than the single cell centroid. We also explore the collective cell dynamics of the
CPM-FEM to an in vitro model of epithelial monolayer dynamics, using the relative
monolayer characteristics to approximate the CPM timescale for use in Chapter 4. The
findings presented here are further generalized to a one-dimensional model of force
distribution within a monolayer, which provides a simple method for approximating
junctional force distribution in vitro using the multicellular geometry. We then apply
these junctional force and cell-cell adhesion predictions in Chapter 4 to model the
mechanotransduction signaling pathway.
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3.2 Methods
In this study, we apply the CPM to simulate epithelial monolayer dynamics (172). The
cell-occupied lattice is superimposed on a finite element lattice to determine substrate
strains from simulated traction forces. In particular, we extend the FMA prediction of
single cell traction forces to predict the traction forces of a multicellular cluster based
on its geometry. Lastly, we predict cell-cell junction forces by requiring that 1) cells
in contact are mechanically coupled through cell-cell junctions, 2) the forces at these
junctions balance net traction forces for each cell, and 3) the junction force is equal and
opposite across a cell-cell adhesion.
3.2.1 Cellular Potts model
The domain of the CPM lattice Ω ⊂ Z2 contains interconnected sites ~x ∈ Ω with spins
σ~x ∈ Z≥0 to identify the configuration of the domain. Each distinct cell-occupied site
is defined by σ~x ∈ N, and an unoccupied site, i.e. extracellular matrix, is defined by
σ~x = 0. The CPM approximates the effective energy for a system configuration using
a Hamiltonian term, where each term reflects a characteristic of biological cells and
together summarize the configuration energy of the system. Here, the Hamiltonian is
given by the sum of three terms
H = Harea +Hcontact +Hdurotaxis, (3.1)
and Boltzmann statistics determine the probability of a possible lattice configuration
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P (H) = e−H/T , (3.2)
where H is the Hamiltonian defined in 3.1, k is the Boltzmann constant, and T > 0 is a
temperature term that captures intrinsic cell motility.
The area term Harea approximates the cell area constraint as a deviation of the cell
area relative to the target area such that
Harea =
∑
σ
λarea
(
a(σ~x)− A0
A0
)2
, (3.3)
where a(σ~x) is the area of a given cell determined by number of lattice sites occupied by
that cell, A0 = 312.50 µm
2 is the target area for all cells, and λarea = 500 is an elasticity
coefficient that maps deviations from the target area to a magnitude of energy.
The contact term Hcontact represents costs due to contact between neighboring
pixels, with different energies associated with cell-cell and cell-matrix interfaces:
Hcontact =
∑
(~x,~x′)
J (σ~x, σ
′
~x) (1− δ(σ~x, σ′~x)), (3.4)
where J(σ~x, σ
′
~x) defines the interaction energy between adjacent lattice sites (x, x
′) and
δ(σ~x, σ
′
~x) is the Kronecker delta function defined as 1 if σ~x = σ
′
~x and 0 otherwise. We
specify the cell-cell interface energy J(σ~x, σ
′
~x) as Jcc and cell-matrix interface energy
J(σ′~x, 0) as Jcm.
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Lastly, the durotaxis term Hdurotaxis introduced in van Oers (174) mimics the
tendency for cell migration along gradients of mechanical strain. In particular, this term
captures preferential cellular extension into lattice sites of higher strain
Hdurotaxis = −g(~x, ~x′)λdurotaxis
(
h (E(ε1)) (~v1 · ~vm)2 + h (E(ε2)) (~v2 · ~vm)2
)
. (3.5)
The λdurotaxis = 1 term determines cell sensitivity to durotaxis; g(~x, ~x
′) is 1 if a cell
extends into a target site ~x′ and -1 if a cell retracts; and v · vm ensures extension and
retraction are greatest parallel to the major and minor principal strain axes, v1 and v2
respectively, and negligible perpendicular to it. The sigmoid function h (E) captures the
preference for stiffer substrates
h (E(ε)) =
α
1 + e−β(E(ε)−Eθ)
, (3.6)
which assumes this preference has a minimal stiffness for spreading and reaches
a maximum α = 10 at rate β = 5 × 10−4 kPa−1 and the half-max stiffness as
Eθ = 15× 103 kPa. E(ε) is the cell perception of substrate strain stiffening
E(ε) = E0
(
1 +
ε
εst
)
, (3.7)
where εst = 0.1 determines the rate of strain-stiffening, ε is the substrate strain, and
E0 = 10 kPa is the Young’s modulus of the substrate. The strain-stiffening only affects
cell perception of strain-stiffening, not the stiffening of the finite element mesh itself
(Section 3.2.2).
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3.2.2 Finite element analysis
To describe the substrate strain that governs durotaxis, we assume that a uniform,
isotropic, and linearly elastic two-dimensional substrate deforms to cellular traction
forces projected from the CPM. The CPM lattice is mapped to the finite element
lattice by relating each CPM lattice element to a finite element node such that
(x, y) = (x ± 1, y ± 1). By applying the preconditioned conjugate gradient method, we
iteratively solve the linear system
Ku = f, (3.8)
for the displacement u at each node, where K is the global stiffness matrix assembled
from the stiffness matrix of each element, and f is the applied traction forces with
constraint u = 0 at the CPM lattice boundary. In maintaining constant material
properties during deformation, the element stiffness matrices K
e
are given by
K
e
=
∫
Ωe
BTDBdΩe (3.9)
where B is the conventional strain-displacement matrix and D is the material property
matrix under plane stress conditions
D =
E
1− ν2

1 v 0
v 1 0
0 0 1
2
(1− v)
 . (3.10)
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relating the Young’s modulus, E = 10 kPa, and Poisson’s ratio, v = 0.45, assuming
planar stress. Lastly, B relates the local node displacements to the local strains by
ε = Bun (3.11)
in which ε is a vector of the strain tensor ε.
3.2.3 Traction forces
Prior work of van Oers and colleagues (174) assume that individual cell geometry relates
to traction forces in the CPM by the FMA. Application of the FMA model to single cell
geometries is previously described by one of the senior authors of this work (186). In
brief, the single cell FMA model assumes that each node i in a CPM cell σ exerts a force
on all other nodes j in the same cell that is proportional to the distance between those
nodes ~di,j,
−→
F i = µ
∑
j
~di,j, (3.12)
where µ is a scaling factor that relates cell geometry to traction forces. For simplicity,
we assume µ = 1 nN µm−1 and report forces as relative arbitrary units (a.u.). As shown
in Lemmon and Romer (186), the resulting traction force at each CPM node is directed
towards the cell centroid with magnitude proportional to the distance from the node to
the centroid.
Here, we extend these previous works of the FMA model to describe the magnitude
and direction of traction forces acting about a point in a multicellular geometry. For
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the multicellular FMA model, we assume that the boundary of two cells constitutes a
cell-cell adhesion such that two or more adjacent cells behave as a single structural unit
or cluster. We define an adjacency matrix A, where A is a Ncell ×Ncell matrix, such that
Aσ,σ′ = 1 if cells σ and σ
′ are in contact, and 0 otherwise. By definition, A is symmetric.
A cluster is defined as the connected components of the undirected graph defined by A.
Thus, the multicellular FMA model defines the traction force at each node in each
CPM cell as directed towards the centroid of the associated multicellular cluster, with
magnitude proportional to the distance from the node to the cluster centroid. Consistent
with this hypothesis, recent experimental evidence supports an increase in traction forces
with increasing multicellular cluster size (187; 188) For the case of a cluster comprised of
a single cell, i.e., a cell lacking cell-cell adhesion, the multicellular FMA and single cell
FMA model are equivalent.
3.2.4 Intercellular tension
By construction, the single cell FMA model dictates that the sum of traction forces of
an individual cell, i.e., the net traction forces
−→
T σ =
∑
i∈σ
−→
F i for cell σ, is equal to 0.
In contrast, using the multicellular FMA model, the net traction forces of an individual
cell Tσ within a cluster may not be equal to 0. Adapting a recent approach by Ng and
colleagues (189), we hypothesize that junction forces are a reaction force, balancing the
net traction force to maintain static equilibrium of each cell in a multicellular cluster.
The multicellular FMA model is applied to calculate Tσ for each cell, and then we impose
mechanical equilibrium on the multicellular clusters by relating the traction force to
force across the cell-cell adhesion, such that for all cells σ,
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∑
σ′∈nσ
~Jσ,σ′ + ~Tσ = 0, for σ ∈ (1, . . . , Ncell), (3.13)
where nσ defines the set of “neighbors” of cell σ, i.e., Aσ,σ′ = 1, and Jσ,σ′ is the junction
force from cell σ′ to cell σ (see S1 Figure). Eq. 3.13 defines Ncell linear equations,
with N2cell unknown Jσ,σ′ terms. We further constrain the junction force calculations by
assuming that junction force pairs are equal in magnitude and opposite in direction, i.e.,
~Jσ,σ′ + ~Jσ′,σ = 0, (3.14)
for all (σ, σ′) such that A(σ, σ′) = 1.
Combining Eqs. 3.13 and 3.14, we arrive at a linear system with a set of Ncell +Njunc
equations and N2cell unknowns (see S1 Figure), where Njunc is the number of intercellular
junctions, which can be determined by the sum of the terms above (or below) the main
diagonal of A, with a maximum value of Ncell(Ncell− 1)/2. In practice, linear systems for
Eqs. 3.13 and 3.14 are determined separately to both the x- and y-components of the
traction and junction forces.
For nearly all cluster arrangements, the resulting linear system is overdetermined.
Analogous to the CPM thermodynamic energy minimization, we assume that the
solution to be the minimization of junction force for each cell pair in the cluster, such
that Jσ,σ′ terms are calculated as the minimum norm least-squares solution to the linear
system (using the MATLAB lsqminnorm function).
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3.2.5 Cell division
We incorporate cell division into the CPM model to reproduce epithelial cell capacity
to proliferate and form a confluent monolayer. For simplicity, we assume that if an
individual cell area exceeds a minimum area threshold, which we define as 2
3
A0, then
individual cells divide with random probability %divide = 0.005, unless otherwise stated.
For cell division, following the prior approach of Daub and Merks, we compute the line of
division for each CPM cell as the line following the minor axis, such that each daughter
cell is of approximately equally area (177).
Briefly, the cellular inertia tensor approximates the minor and major axis of the cell
(Eq. 3.15).
I(σ) =
 ∑x∈C(σ)(y − Cy(σ))2 −∑x∈C(σ)(x− Cx(σ))(y − Cy(σ))
−
∑
x∈C(σ)(x− Cx(σ))(y − Cy(σ))
∑
x∈C(σ)(x− Cx(σ))2
 .
(3.15)
The dividing cell, σ, has lattice points defined by C(i) = {~x ∈ Z2} and center of mass
C(i) =
1
|C(i)|
∑
~x∈C(i)
~x. (3.16)
The division line is therefore the minor axis such that
~d = Cy + b(σ~x − Cx), (3.17)
where Cy and Cx are the x and y center of mass, respectively, for dividing cell σ~x, and b
is the slope of ~d
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b =
λb − Ixx
Ixy
, (3.18)
in which λb = max |λI |. The lattice sites ~x of the proliferating cell are then sorted relative
to the division line, with half of the cell area assigned to the parent cell σ and half to
the daughter cell σ′. The daughter cell inherits the gene expression and phenotype of
the parent cell for the purposes of Chapter 4 and is assigned the index σ′ = Ncell + 1, in
which Ncell is the number of cells.
3.2.6 Numerical simulations
The CPM map is initialized as uniformly distributed pixels of size 100 x 100, for which
each pixel corresponds with a size of 2.5 µm. Initial seeding is dispersed on the cell
map excluding the outermost boundary with random probability, p = 1/(4A0). An
unloaded finite element mesh of size 101 x 101 forms the nodes of attachment for
cells of the CPM map, in which each cell-occupied pixel occupies four nodes such that
xi,j → (xi−1,j−1, xi,j−1, xi−1,j, xi,j). To calculate forces from the CPM map, pixels are
first mapped to the finite element substrate by identifying the corresponding nodes. At
a given instant, the single cell or multicellular geometry is sufficient to define cellular
traction forces at each node, using the single or multicellular FMA model, as described
above, respectively. The resulting traction forces govern the displacement at each node
and determines the strain in the finite element mesh, which in turn is used in evaluating
Hdurotaxis.
Cell movement consists of copy attempts of randomly selected pixel at each Monte
Carlo step (MCS). For each pixel to have equal probability of selection, each MCS has
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a total of 104 copy attempts. For each copy attempt, a voxel is selected and randomly
perturbed; the sum of interaction energies with each pixel in the Moore neighborhood,∑
J(σx,x′), determines the Hcontact term. Lastly, the cell area before and after the
copy attempt provides the Harea term. Together, the net change in the Hamiltonian
associated with that copy attempt, i.e. ∆H(σx,x′) =
∑
H, provides the local energy for
the cell before and after the copy attempt. The copy attempt is accepted (σx → σ′x) with
probability determined by the partition function (Eq. 3.2) for ∆H > 0 and probability 1
for ∆H < 0.
For parameter analysis, the parameter set consisted of each combination of cell-cell
interaction energies and cell-matrix interaction energies, Jcc and Jcm, respectively, each
repeated with a uniquely seeded random number. The interaction energies were grouped
by cell-matrix interaction energy, averaged across each simulation, compared for each
ratio of cell-cell to cell-matrix contact inhibition. The confluence is determined by the
ratio of total cell occupied pixels to the total grid area. The cell area is number of pixels
occupied by each unique cell state, and the cell count is the number of unique states.
3.2.7 Cells and reagents
All cells were cultured in a humidified atmosphere at 37 ◦C with 5% CO2. Human
MCF10A mammary epithelial cells were obtained from the National Cancer Institute
Physical Sciences in Oncology Bioresource Core Facility, in conjunction with American
Type Culture Collection (Manassas, VA). MDCK II cells were a gift of Rob Tombes
(VCU). MCF10As were maintained under standard culture conditions in DMEM/F-12
HEPES (Life Technologies, Carlsbad, CA), supplemented with 5% horse serum, 0.05%
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hydrocortisone, 0.01% cholera toxin, 0.1% insulin, 0.02% EGF and 1% antibiotics.
MDCK II cells were maintained under standard culture conditions in DMEM (Life
Technologies, Carlsbad, CA) supplemented with 10% fetal bovine serum and 1%
antibiotics. Purified recombinant active TGF-β1 was purchased from Sigma Aldrich (St.
Louis, MO). Immunofluorescence imaging was conducted using the following primary
antibodies: Ms anti-Hu E-cadherin (HECD-1, Abcam, Cambridge, United Kingdom),
Ms anti-Ms N-cadherin (BD Biosciences, San Jose, CA), Rb anti-Hu FN (Abcam,
Cambridge, United Kingdom), Ms anti-Hu LTBP-1 (RD Systems, Minneapolis, MN),
Rb anti-Hu Smad2 (86F7 , Cell Signaling Technology, Danvers, MA), Dapi (Thermo
Fisher Scientific, Waltham, MA). F-actin images were acquired by labeling cells with
AlexaFluor555 Phalloidin (Life Technologies, Carlsbad, CA).
3.2.8 Microcontact printing
Microcontact printed square islands were generated as previously described [Tan et al.,
2004]. Briefly, 250 µm x 250 µm squares were constructed by generating a negative
mold template on a silicon wafer made from an epoxy-type, near-UV photoresist
(SU-8; Microchem) using traditional photolithographic techniques. A replica-mold of
poly(dimethylsiloxane) (PDMS; Sylgard 184, Fisher Scientific, Hampton, NH) raised
patterns were be coated with 100 µg/ml laminin (Sigma Aldrich, St. Louis, MO) for 2
hours at 37 degree C. Stamps were then rinsed in dH2O and dried with nitrogen gas.
The laminin square islands were then stamped onto a thin layer of UV-treated PDMS
on top of a glass coverslip. 2% Pluronics F-127 in phosphate-buffered saline (PBS) was
used to prevent cells from adhering outside of the laminin-stamped areas. Coverslips
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were rinsed in PBS prior to cell seeding. Efficiency of protein transfer was confirmed by
Immunofluorescence labeling of the ECM protein.
3.2.9 Immunofluorescence microscopy
MCF10A and MDCKII cells were plated on microcontact-printed laminin islands at
cell densities that resulted in near-confluent monolayers. After 6 hours, samples were
rinsed in culture medium to remove non-adherent cells. Cells were cultured for 18 hr
and were then transferred to EGF- and serum-free culture conditions for 2 hr to induce
an epithelial phenotype. Cells were then incubated with or without TGF-β1 for an
additional 48 hours. Cells were permeabilized with 0.5% Triton in 4% paraformaldehyde
for 2 minutes, then incubated in 4% paraformaldehyde for 20 minutes. Several PBS-rinses
were performed, followed by blocking in 0.1% BSA and labeling with primary antibody
for 30 minutes at 37 degree C. Cells were then blocked again in 0.1% BSA and incubated
with the appropriate secondary antibody for 30 minutes. Images were acquired on a
Zeiss AxioObserver Z1 fluorescence microscope using ZEN2011 software.
3.2.10 Cell area and cell number quantification
Cell area and cell number were determined by analyzing immunofluorescence images
of F-actin and nuclei via an author-written image processing algorithm in MATLAB.
Binary masks of nuclei were generated by thresholding grayscale nucleus images; objects
in the binary mask were counted to determine total cell number. To determine cell size,
the centroid of each object in the binary mask was determined using the regionprops
function. Nuclei centroids were used to generate a Voronoi diagram, which consists of a
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series of polygons that have edges that are equidistant from neighboring nuclei. Previous
studies have demonstrated that Voronoi diagrams reasonably predict cell boundaries in
an epithelial monolayer, and provide a more consistent quantification of cellular size as
opposed to quantification of protein markers in the cell-cell junction, whose expression
and localization changes as TGF-beta dose increases [REF]. Cell area was calculated
for each cell by summing the pixels in each Voronoi polygon, and were averaged across
the 250 µm x 250 µm colony. Spatial localization of cell number and cell area were
determined by binning nucleus centroids into a 5 x 5 grid. Cell counts in each bin were
totaled, and cell areas for each bin were averaged if the nuclei centroid was contained
within the bin. Spatial localization data was further combined into either corner bins,
edge bins, or interior bins, such that there were no overlap between the three regions
(i.e., corner bins were not included in the edge region).
3.2.11 FRET analysis
To measure force on cell-cell junctions, Fluorescence Resonance Energy Transfer
(FRET)-based, full-length E-cadherin tension biosensors were stably transfected into
MDCK II cells. Epithelial square islands were cultured as stated above, and images were
acquired on a Zeiss LSM 710 laser scanning microscope using ZEN2011 software. Briefly,
mTFP (donor) and mEYFP (acceptor) fluorophores were imaged utilizing spectral
unmixing at 458 nm excitation. The acquired intensity images were manually masked
through ImageJ. Background subtraction and removal of saturated pixels was then
performed via an image processing algorithm in Python as previously described (190).
FRET ratio was determined by obtaining the acceptor/donor ratio and multiplying with
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a binary mask of the junctions. This allowed for inspection of FRET pixels of interest
within outlined cell-cell junctions.
3.2.12 Statistical analysis
Simulated data was exported to Prism 8 (GraphPad Software Inc) for analysis. Statistical
significance, indicated by a p-value less than 0.05, was determined by one-way ANOVA
across each TGF-β dosage, ratio of interaction energies, and spatial localization.
3.3 Results
3.3.1 Multicellular traction forces drive formation of epithelial
monolayers
Prior studies from van Oers, et al demonstrated that a hybrid CPM-FEM model can
predict cellular spreading and organization based on cell-generated traction forces,
resulting strains in the substrate, and duratactic driven migration in the CPM. To
expand this model to adherent cell monolayers, we incorporated several advancements:
first, cellular traction forces were predicted from the FMA model (186) based on a cell
cluster geometry, not on individual cells. As such, cells in contact with neighboring cells
“adhere” and begin to generate traction forces as a cohesive unit. Second, we assume
that each cell in a multicellular cluster still maintains a static equilibrium, as has been
suggested previously (191). As such, we require the force acting on cell-cell junctions to
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counter the net traction force for each cell, as illustrated in a simple two cell example
(Fig. 3.1 C, left).
Figure 3.1. Simulated cells (red pixels) migrate on a finite element substrate that
responds to cell-generated traction forces. Traction forces are calculated based on either
(A) individual cell geometries or (B) multicellular clusters. (C, left) Representation of
traction forces with resulting strain for multicellular geometries, and (C, right) inset of
time points from panel B.
Figure 3.1 depicts simulated cells (red pixels) with corresponding scaled substrate
strains (black vectors) for two scenarios. In the first, traction force is calculated from
the FMA about the single cell geometry and each cell is in static equilibrium. As a
result, the net imbalance for each cell is zero and no force is transferred across the
cell-cell junction (Fig. 3.1 A). In the second scenario, traction force is calculated from
FMA about the multicellular geometry and each cluster is in static equilibrium (Fig. 3.1
B). The net force imbalance for each cell is balanced by the intercellular tension, which
transfers the traction force to neighboring cells. Without redistribution of cytoskeletal
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stress to neighboring cells across cell-cell junctions, cellular alignment is localized
and multicellular structures behave as partially cooperative networks with discordant
substrate strains (Fig. 3.1 A, S1 Video), as demonstrated by van Oers et al (174). In
contrast, traction force distribution across cell-cell junctions to neighboring cells results
in highly cooperative networks with a uniform spatial gradient of substrate strains. The
formation of these cohesive multicellular clusters resembles an epithelial monolayer with
preferential localization towards the boundary (Fig. 3.1B, S2 Video). In the resulting
multicellular clusters, net traction forces have a magnitude and direction at any given
point proportional to the FMA about that point in the cluster, resulting in a linear
gradient of substrate strain oriented radially towards the cluster centroid (Fig. 3.1C, S2
Figure).
3.3.2 Spatiotemporal dynamics of monolayer confluence
Preliminary simulations demonstrated the formation of a subconfluent monolayer-like
sheet, which alters the spatial distribution of monolayer stress. To better predict the
spatiotemporal dynamics of an in vitro epithelial monolayer, we incorporated cellular
proliferation into the CPM to account for cell division dynamics, and then compared the
spatiotemporal dynamics with cultured epithelial cells (Fig. 3.2, S2 Figure; see Methods
for a more in-depth discussion). Mammary breast epithelial cells (MCF10A) were seeded
onto microfabricated PDMS substrates with a 250 µm x 250 µm microcontact-printed
area of laminin (Fig. 3.2A). Epithelial monolayers reached confluence over approximately
24 hours. Simulated cells exhibit similar patterning representative of MCF10A
confluence dynamics (Fig. 3.2B). To estimate the rate of proliferation in the simulations,
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immunofluorescence images were analyzed at 0, 6, 12, 18, and 24 hours and quantified
for confluence as a function of time (Fig. 3.2C, S3 Video). The half maximal confluence
for simulations and experiments indicate that 75 Monte Carlo steps (MCS) corresponds
to 6 hours of experimental time (Fig. 3.2B, C). This was used to estimate a simulated
division probability of 0.5% per time step. These results demonstrate that simulated
spatiotemporal dynamics approximate cellular dynamics observed in vitro and agree
with previous studies (192).
Figure 3.2. Spatiotemporal dynamics of simulated and in vitro tissue patterning.
Visual comparison of time points from initial seeding to confluence illustrates parallels
between (A) in vitro and (B) simulated spatial patterns. (C) Confluence, the fraction of
total cell area to total substrate area, is shown as a function of time or Monte Carlo
Steps (MCS), for in vitro and in silico experiments, for different conditions. Other
parameters: Time scale: 4.8 min/1 MCS, Jcm = 2.5.
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3.3.3 Altered interfacial energies mimic changes in contact
inhibition
With the key addition that traction forces are governed by the FMA model about the
cluster geometry rather than the single cell geometry, the previous results illustrate
distinct spatial patterning representative of epithelial monolayers. We next utilized
our model to simulate epithelial monolayer and associated EMT-like dynamics. One
key aspect of the epithelial phenotype is contact inhibition: that is, the propensity
of a cell to stop migration and proliferation when a neighboring cell is encountered
(193; 194). As epithelial cells undergo EMT and become more mesenchymal, contact
inhibition is reduced (195). To mimic the effects of EMT in epithelial monolayers
in our multicellular FMA model, we varied the relative interaction energies between
neighboring cells in the CPM, which simulates changes in contact inhibition. We varied
the ratio of interaction energies at the cell-cell and cell-matrix interfaces, Jcc and Jcm,
respectively (see Materials and Methods, Eq 3.4), for the single cell (Fig. 3.3A–D) and
multicellular (Fig. 3.3E–H) FMA models. The magnitude of the respective energies
represents a prohibitive interaction, i.e., a higher Jcc/Jcm ratio reflects increased contact
inhibition between adjacent cells. For each simulation, we measured the steady-state
monolayer confluence, average cell area, total cell count, and relative net cellular traction
forces, averaged over 5 simulations with distinct random cell seeding, and plotted these
measures as a function of the Jcc/Jcm ratio. These simulations were then repeated for 3
distinct values of cell-matrix interaction energies, Jcm.
Results indicate similar trends between the single cell and multicellular FMA
models, with the exception of net cellular traction force, which must be zero for a
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Figure 3.3. Parameter sweep of interaction energies. (A-D) Single cell FMA and (E-H)
multicellular FMA simulated confluence, cell area, cell count, and traction force, shown
as a function of the ratio of cell-cell contact inhibition to cell-matrix inhibition
(Jcc/Jcm), varying Jcm values.
cell in static equilibrium in the single cell FMA model (Fig. 3.3D). Beyond a critical
point (Jcc/Jcm = 2), high cell contact inhibition precludes the formation of confluent
monolayers (Fig. 3.3A, E). Further, we find that the time course of monolayer confluence
only weakly depends on cell contact inhibition below this critical point, i.e. for conditions
that form confluent monolayers (Fig. 3.2C). Similarly, increasing cell contact inhibition
results in smaller cell area (Fig. 3.3B, F) and higher cell count (Fig. 3.3C, G). In the
multicellular FMA model, net traction force per cell decreases as the Jcc/Jcm ratio
increases. We find that higher substrate inhibition, i.e., increased Jcm, tends to increase
the sensitivity to the Jcc/Jcm ratio for all measures. Thus, these data indicate that a loss
of contact inhibition leads to larger cells, lower cell count, and in extreme cases, loss of
confluence.
49
CHAPTER 3. CPM
3.3.4 Decreasing contact inhibition increases cell size and
decreases cell number
The above results suggest that cells in the multicellular FMA model resemble the
archetypal phenotype of epithelial cells undergoing EMT. With decreased cell-cell contact
inhibition (i.e., smaller Jcc/Jcm ratio), simulated cells exhibit the characteristic increased
spreading and decreased proliferation of the mesenchymal phenotype, while at increased
cell-cell contact inhibition (i.e., larger Jcc/Jcm ratio), simulated cells exhbit decreased
spreading and increased proliferation characteristic of the epithelial phenotype. Together,
these results indicate that this parameter may serve as a suitable comparison to in vitro
models of growth factor induced EMT. We thus compared these results to experiments
in which EMT was induced by the soluble growth factor TGF-β, as has previously been
detailed (44). Representative immunofluorescence images of MCF10A cells treated with
increasing dosages of TGF-β illustrate a phenotypic switch from cortical actin, which
is typically observed in epithelial cells, to pronounced actin stress fibers associated
with the mesenchymal phenotype (Fig. 3.4A). In these confluent monolayers, MCF10A
average cell count decreases and average cell area increases for increase TGF-β doses
(Fig. 3.4B, D). As in Fig. 3.3, we observe similar trends in simulations for decreasing cell
contact inhibition, although with a weaker dependence than observed in vitro (Fig. 3.4C,
E). Thus, we find that cell contact inhibition similarly regulates the cellular geometry
averaged over the confluent monolayer in both simulation and experiment.
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Figure 3.4. Morphological characterization of the epithelial phenotype with
TGF-β-induced EMT. (A) Representative immunofluorescent images of experimental
illustrate a confluent MCF10A monolayer bounded to the 250 x 250 µm microfabricated
square; scale bar = 50 µm. In vitro (B, D) and simulated (C, E) average cell count and
cell area for the confined geometry are shown for each TGF-β dosage and ratio of
contact interaction energies, respectively. Sample size n=3 for in vitro experiments. *
with line denotes significance between each TGF-β dosage or each contact energy ratio.
3.3.5 Cell-cell junction force maintains mechanical equilibrium
of multicellular clusters
A key advance of the multicellular FMA model is the prediction of forces acting on
cell-cell junctions. By assuming static equilibrium and applying a force-balance principle,
cell-cell junction force was predicted as a reaction force that balances traction forces of
the monolayer (described in detail in Methods). Cell-cell junction force magnitudes are
shown on the boundaries between neighboring cells in simulated monolayers (Fig. 3.5D).
To examine spatial trends, we segmented the simulation domain into a 5 x 5 grid of
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bins, and calculated the mean junction force magnitude within each bin (Fig. 3.5E).
The spatial distribution of junction forces is pronounced, with the largest forces in the
interior and smallest in the corners (Fig. 3.5F). However, interestingly, we find minimal
variation in the spatial trends between low, medium, and high contact inhibition ratios.
Figure 3.5. Intercellular interaction energy reflects TGF-β effects in vitro. (A) In vitro
FRET intensities in MDCK II cells. (B) Corresponding heatmaps for average FRET
intensities are binned into a 5 x 5 grid, and (C) their associated bar graphs averaged at
the corners, edges, and interior for 0, 2, and 4 ng/mL TGF-β dosages; n=3. (D)
Simulated intercellular tension is depicted as the net magnitude for high, medium, and
low interaction energy ratios. (E) Intercellular tension magnitudes are shown as a 5 x 5
grid with (F) their associated bar graphs averaged at the corners, edges, and interior;
n=5, * with line denotes significance between each location.
We next sought to compare these with experimentally-measured junction forces.
To measure cell-cell junction forces experimentally, Madin-Darby Canine Kidney Cells
(MDCKII) cells were stably transfected with a full-length E-cadherin force sensor, as
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previously described (196). Briefly, the force sensor consists of two fluorophores coupled
by a polypeptide that exhibits elasticity. The two fluorphores are designed such that,
when in close proximity, the pair exhibits Forster Resonance Energy Transfer (FRET):
that is, emission light from the first fluorophore is absorbed by the second fluorophore,
which emits light. As the sensor is stretched and the fluorophore pair moves apart,
the excitiation of the second fluorophore by the first fluorophore decays, resulting in a
loss of FRET excitation relative to excitation of the first fluorophore. This force sensor
was inserted into E-Cadherin, which comprises the homophilic binding event in cell-cell
junctions known as adherens junctions. Validation and functionality of this sensor
has been previously demonstrated (197; 198). EMT was again induced by increasing
dosage of (TGF-β) (Fig. 3.5A). FRET ratio reflects the energy transfer between the two
fluorophores, in which FRET ratio is inversely proportional to tension on the FRET
force sensor: high FRET ratio indicates low tension and low FRET ratio indicates high
tension. Representative pseudocolored images of the processed FRET ratio are shown
in Fig. 3.5A. We next investigated if spatial patterns of junction forces were established
in these confluent monolayers. We again segmented images of the the local net FRET
ratios into a 5 x 5 grid. In the absence of TGF-β, colonies illustrated a nearly spatially
uniform low FRET ratio, indicating high cell-cell tension throughout the monolayer
(Fig. 3.5B). TGF-β treatment increased FRET ratio, indicating a drop in overall tension.
Additionally, a small spatial gradient was established, with higher FRET ratios (lower
cell-cell tension) in the corner and edges and lower FRET ratios (higher cell-cell tension)
in the interior of the monolayer, consistent with a spatial gradient of larger junction
forces in the center and decreasing towards the edges and corners (Fig. 3.5C).
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Together, these data indicate that simulated spatial gradients of cell-cell junction
force are best suited for comparison to experimental measures of TGF-β-treated colonies.
Furthermore, simulated cell-cell junction forces predict a spatial trend of decaying
cell-cell tension from interior to periphery.
3.3.6 Individual cell geometry spatial patterns
Summarizing our results presented thus far, we found that the multicellular FMA
model reproduces contact inhibition-dependent trends for average cellular geometry (i.e.,
cell size and count), but underestimates this dependence compared with experimental
observations. Further, our model qualitatively predicts trends for spatial patterns of
cell-cell junction forces in TGF-β-treated monolayers, but overestimates the magnitude
of the spatial gradient, in comparison with experiments. We hypothesize that these
discrepancies arise from an underestimation of cell size distribution throughout the
monolayer in response to changes in contact inhibition. That is, individual cell size
changes in response to TGF-β treatment due not only to loss of cell contact inhibition,
but also to additional signaling not currently present in our model. To investigate this,
we again segmented immunofluorescence images of MCF10A cells and binned cell area
as before into a 5 x 5 grid (Fig. 3.6 A). Consistent with overall monolayer averages,
cell area increased with increasing TGF-β dose. Evaluating the average cell area in the
corner, edge, and interior of the monolayer reveals an overall increase in cell area at the
periphery of the square, with the largest cell area localized to the corners in both low and
high TGF-β dosages (Fig. 3.6 A). Reduced contact inhibition by treatment with TGF-β
accentuates this trend, resulting in a large spatial gradient in cell area (Fig. 3.6 B). In
54
CHAPTER 3. CPM
contrast, simulated cell area exhibited substantially reduced spatial variation compared
to experimental cell area (Fig. 3.6 C). Furthermore, the effects of contact inhibition
had a relatively minimal effect on spatial variation of cell area, resulting in slightly
increased cell area at the monolayer interior (Fig. 3.6 D). Thus, the lack of accounting
for heterogeneous cellular properties, specifically cell area, is a key limitation of our
model. Since cells undergo profound phenotypic changes throughout EMT, it would
be reasonable that these changes lead to parameter changes within the CPM for each
individual cell; incorporating these changes in cell phenotype into the CPM component
is a primary future goal for the model development.
Figure 3.6. Individual cell geometry spatial patterns (A) In vitro heatmaps for binned
cell area treated with 0, 2, and 4 ng/mL TGF-β and (B) their associated bar graphs for
average corner, edge, and interior; n=3. (C) Simulated heatmaps for binned cell area at
high, medium, and low contact inhibition and (D) their associated bar graphs; n=5.
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One-dimensional model of junction force distribution
It is instructive to consider junction forces in a simple one-dimensional geometry, to both
illustrate our approach and explain the perhaps counterintuitive prediction that larger
traction forces at the periphery result in larger junction forces at the center. For this
simple geometry, the traction and junction force magnitudes can be solved analytically,
and further, these analytical results provide an explanation for some of the discrepancies
between experiments and simulations noted above.
Consider a linear array of 2n cells of length L that are arranged and coupled
in a line, such that the cell junctions are located at positions (−nL, 0), (−(n +
1)L, 0), . . . , (0, 0), . . . , ((n − 1)L, 0), (nL, 0) where T = nL is the length of half of the
monolayer or tissue (Fig. 3.7C). Note that the y position is insignificant, since all forces
are oriented in the x-direction. The centroid of the tissue aligns with the origin, (0, 0),
which is the junction on the left edge of cell 1, and thus the net traction force in each
cell will be pointed towards this position. Further, we assume that each cell has f focal
adhesions, uniformly spaced along the length of the cell L, and that traction forces are
generated only at the focal adhesion positions. In the illustrated example, f = 4.
Traction forces generated at each focal adhesion are thus proportional to distance
from the origin, and the net traction force for a given cell is the sum of all traction
forces over all focal adhesions. We can show that for cell k, with left edge at position
((k − 1)L, 0) and right edge at position (kL, 0), the net traction force is given by
−→
T k = (−µLf(k − 12), 0), where µ is the appropriate scaling factor. For the rightmost
cell, cell n,
−→
T n = (−µLf(n− 12), 0). For mechanical equilibrium at cell n, this traction
force must be balanced by the junction force from cell n − 1 to cell n, such that
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Figure 3.7. One-dimensional generalization for multicellular forces at mechanical
equilibrium. (A) Representative snapshot of the traction and junction forces in the
multicellular CPM model. (B) Plots of the traction and junction forces from the CPM
simulations shows that traction force scales linearly with distance from monolayer
centroid (blue line) and intercellular tension drops off quadratically from the centroid
(red line).
−→
J n,n−1 = (µLf(n− 12), 0). By assumption, net forces at the cell-cell junction are also in
equilibrium, such that junction force pairs are symmetric, i.e., equal in magnitude and
opposite in direction, such that
−→
J n−1,n = (−µLf(n− 12), 0).
Next considering forces on cell n− 1, the junction force from cell n− 2 to cell n− 1
must balance both the net traction force
−→
T n−1 = (−µLf((n − 1) − 12), 0) and junction
force
−→
J n−1,n, such that
−→
J n−1,n−2 = (µLf(2n− 2), 0). Similarly, junction force from cell
n − 3 to cell n − 2,
−→
J n−2,n−3 = (µLf(3n − 92), 0). In general, we can show that the
intercellular tension from cell k to k + 1,
57
CHAPTER 3. CPM
−→
J k+1,k =
(
1
2
(n2 − k2)µLf, 0
)
=
(
1
2
µf
(
T 2
L
− Lk2
)
, 0
)
. (3.19)
Thus, the junction force at the center onto the left edge of cell 1,
−→
J 1,0 =
(µLn2f/2, 0) = (µT 2f/(2L), 0). This simple geometry arrangement predicts larger
magnitude junction forces in the center, and further illustrates a quadratic drop-off (due
to the −k2 term in the magnitude of
−→
J k+1,k) that is predicted as junction position k
increases towards the periphery. A representative example of the CPM model illustrates
the distribution of traction forces (blue) and junction forces (red) in a confluent
monolayer (Fig. 3.7B) and both the linear increase in traction force magnitude from the
monolayer centroid and the quadratic drop-off in junction force magnitude (Fig. 3.7B).
Thus, for a monolayer of a given size, i.e., fixed T , Eq 3.19 predicts that for a
smaller cell size (decreased L and thus increased n), the magnitude of junction forces are
larger throughout the monolayer, which is consistent with experimental measurements of
lower FRET ratios (i.e., higher tension) in non-treated epithelial monolayers (Fig. 3.5C).
Further, in TGF-β-treated monolayers, more mesenchymal-like larger cells at the
monolayer periphery would be expected to have more focal adhesions per cell, in contrast
with epithelial-like smaller cells in the interior. Additionally, while larger cells at the
periphery will reduce junction forces locally, due to the cumulative nature of junction
forces required to maintain mechanical equilibrium originating at the periphery, this local
reduction in junction forces would be expected to have a greater influence on interior
junction forces. All of these considerations would be predicted to reduce the magnitude
of the spatial gradient, consistent with smaller spatial gradients observed experimentally.
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We can further generalize this example and consider the continuous limit in the
spatial dimension, in which the traction forces in the x-direction at position x are given
T (x) = −µf(x)x, (3.20)
where f(x) is the spatial distribution of focal adhesions per unit length. Junction forces
at position x are then by definition the second moment of area, evaluated from the
cluster periphery to position x, where again x = 0 corresponds with the cluster center,
J(x) = −µ
∫ x
T
f(x′)x′dx′. (3.21)
For uniform focal adhesion distribution, f(x) = f/L, we can integrate Eq 3.20, and using
x = kL, the result is equivalent to Eq 3.19.
Although the CPM predictions of force spatial distributions generally agree with
previous findings, characteristics of the monolayer do not fully capture monolayer
dynamics observed in vitro. In particular, trends in cell area and count are not well
represented in variations of contact penalties for the CPM. While TGF-β is known to
increase cell spreading, the CPM uniformly constrains cell area to a target area. By
varying the target area in future iterations, the CPM would better capture capture the
effects of EMT on cell area and resulting spatial patterning.
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Gene regulation of the
epithelial-mesenchymal program
4.1 Introduction
A prevalent EMT regulatory network involves a group of master transcription factors
with micro-RNA counterparts that facilitate a switch between cell-cell and cell-substrate
adhesion (178; 179; 180; 183; 184). Previous experimental and computational work
has developed and characterized an EMT-associated signaling network capable of
regulating key epithelial and mesenchymal adhesion molecules (42; 181). Consisting of
the EMT-TFs SNAIL1 and ZEB1 and microRNAs miR-34 and miR-200, the network
regulates the epithelial marker, E-cadherin, and mesenchymal marker, N-cadherin
(Fig. 4.1). Characterizing the gene regulatory function of the EMT-TFs in the context
of EMT-associated features will improve our understanding of phenotype states in
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the EMT spectrum, as well as present opportunities for therapeutics targeted at
EMT-TFs (182; 183; 184).
The Tian model, also referred to as the cascading bistable switch (CBS) model,
provides an intracellular signaling framework appropriate for the application of phenotype
tracking in a heterogeneous cell population. This EMT-GRN has a temporal and dosage-
dependent response to exogenous TGF-β, which produces a latent intermediate
mesenchymal phenotype capable of reversion to an epithelial phenotype Fig. 4.2. Firstly,
introduction of TGF-β at particular thresholds drives the EMT-GRN in favor of the
mesenchymal phenotype. Secondly, we may substitute a separate perturbation, which
stems from cell-cell junctions, as an input to the intracellular regulatory network with
similar dynamics to TGF-β.
Loss of force across E-cadherin junctions transitions epithelial cells to a reversible
intermediate mesenchymal phenotype. Destabilizing the regulatory network with
exogenous perturbations sufficiently drives EMT to an irreversible mesenchymal
phenotype. In Chapter 4, we propose that the GRN is susceptible to mechanical
perturbation from intercellular tension, and introduce transduction of junctional forces
to intracellular signaling cascades as a mechanism for inducing EMT.
To address the discrepancies in experimental and computational observations
described in Chapter 3 we defined phenotype cellular properties which are regulated by
an EMT-associated gene regulatory network. First, we integrated the computational
framework established in Chapter 3 with an intracellular signaling network that regulates
well-characterized epithelial and mesenchymal genes. Next, we coupled mechanical
feedback at cell-cell junctions to a molecular signaling pathway, i.e. β-catenin, associated
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with loss or gain of cell-cell junctions to further understand how the intracellular
signaling network generates EMT-associated features (199; 200). Key findings will
provide feedback to the larger computational framework by predicting phenotype
heterogeneity due to complementary dynamics at the molecular and cellular scale
throughout the EMT program. A particularly interesting application of this multiscale
approach is tracking of the spatiotemporal progression of phenotypic states in an
epithelial monolayer.
4.2 Methods
Phenotype-specific properties associated with EMT reflect a switch in cellular motility.
Morphological changes arising from EMT necessarily change the thermodynamic
behavior of a cell: mesenchymal cells have larger volumes, decreased cell-cell adhesion,
and larger traction forces (201). Hence, the Hamiltonian terms of Eq. 3.1 are unique to
each phenotype. For this reason, the phenotypic state of each cell must be known prior
to calculating the Hamiltonian term.
To understand how the cadherin GRN contributes to EMT, we coupled mechanical
feedback at cell-cell junctions to molecular signaling known to be linked with loss or gain
of cell-cell junctions. Gene expression was tracked for each cell cell and will be useful
in later studies to predict localized regions of EMT. In doing so, we were able to assign
phenotype associated behavior on a cell-by-cell basis. Additionally, these findings will be
useful in simulating secretion of EMT biomarkers that contribute to aberrant EMT in an
autocrine and paracrine fashion.
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4.2.1 Gene regulatory Network
The EMT-GRN of the CBS model consists of two double negative feedback loops,
comprised of transcription factors and miRNA, which act on the epithelial gene for
E-cadherin and mesenchymal gene for N-cadherin (Fig. 4.1). TGF-β initiates EMT
through upregulation of mRNA for transcription factor SNAIL1 (snail1 ). However,
miR-34 represses translation of mRNA snail1 to SNAIL1, which in turn inhibits miR-34
in a negative feedback loop. The second negative feedback loop reflects the first, but
comprised of mRNA zeb producing transcription factor ZEB and inhibition by miR-200.
Both feedback loops downregulate the epithelial gene and upregulated the mesenchymal
gene.
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Figure 4.1. Schematic of the EMT gene regulatory network dynamics. Exogenous
TGF-β initiates the gene regulatory network to downregualate E-cadherin and
upregulate N-cadherin. TGF-β is also an output of the network, which acts in a positive
feedback loop.
The sensitivity to exogenous TGF-β stimulates a partial mesenchymal phenotype at
intermittent exposure and mid-range concentrations (Fig. 4.2). Endogenous production
of TGF-β can form a self-sustaining feedback loop if exogenous TGF-β is either
persistently applied or the concentration is sufficiently large surpasses, resulting in an
irreversible mesenchymal phenotype.
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Figure 4.2. Representation of the phenotype bistable switch predicted by the Tian
model. Epithelial cells (shown in green) exist upstream of the first switch, saddle node 1
(SN1), wherein exogenous TGF-β dose and exposure time are minimal. The reversible
intermediate mesenchymal phenotype (shown in yellow) is located between SN1 and
SN2. Lastly, the irreversible mesenchymal phenotype is shown downstream of SN2
where exogenous TGF-β concentrations are maintained for sustained periods, whether
through repeated exposure or high dosage.
The EMT-GRN represented schematically in Fig. 4.1 was described using a system
of ordinary differential equations (ODEs) with each variable having Hill function-like
dynamics. All terms are for endogenous concentrations, and exogenous TGF-β was
simulated at a constant value of 3 nM.
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where [T], [s], [S], [z], [Z], [R2], [R3], [E], and [N] denote endogenous TGF-beta, snail,
SNAIL, zeb, ZEB, miR-200, miR-34, E-cadherin, and N-cadherin, respectively.
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Parameter Symbol Value
TGF-β [T] 0.16
snail1 mRNA [s] 0.01
SNAIL1 [S] 0.01
miR-34 [R3] 0.38
zeb mRNA [z] 0.03
ZEB [Z] 0.01
miR-200 [R2] 0.35
E-cadherin [E] 3.20
N-cadherin [N] 0
Table 4.1:. State variables are shown for the system described in Eq. 4.1–4.9.
The output for the EMT-associated gene regulatory network is shown Fig. 4.3. A
constant input of exogenous TGF-β was applied and gene expression was tracked for a
simulated time of 18.75 days. The deterministic solution reveals two stable states with an
intermediate state, indicated by partial expression of the epithelial gene and mesenchymal
gene. Low expression of endogenous TGF-β corresponds to an intermediate phenotype
in which the epithelial marker is partially downregulated and the mesenchymal marker is
partially upregulated. An increase in endogenous TGF-β after persistent stimulation by
exogenous TGF-β drives the phenotype towards an irreversible mesenchymal phenotype.
4.2.2 β-catenin signaling
Mechanical induction of the EMT-TFs occurs during destabilization of cell-cell
adhesions: the cytoplasmic domain of E-cadherin is cleaved, releasing β-catenin for either
degradation or nuclear translocation to activate EMT-TFs SNAIL1 and ZEB (44; 202).
Therefore, the β-catenin signaling cascade provides a mechanotransduction pathway for
coupling junction force at the E-cadherin complex to the EMT-GRN.
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Figure 4.3. The endogenous TGF-β expression creates a self-sustaining positive
feedback loop resulting in the irreversible mesenchymal phenotype state.
Formation of E-cadherin junctions requires both intracellular and extracellular events.
Importantly, β-catenin is a primary regulatory protein in the intracellular formation
of cell-cell junctions. When β-catenin is located at E-cadherin junctions, epithelial
cells maintain the epithelial phenotype (199). However, when β-catenin translocates
to the nucleus, whether by mechanical or chemical E-cadherin disruption, epithelial
cells switch to a mesenchymal phenotype (200). This provides a mechanotransduction
signaling pathway for affecting the phenotype of each cell in the CPM by acting on the
EMT-associated gene regulatory network.
The three states of β-catenin are cytoplasmic, E-cadherin bound, and proteasome
bound. Cytoplasmic β-catenin freely binds with either E-cadherin for junction formation
or the destruction complex for proteasomal degradation (Eq. 4.12). Proteasomal
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degradation of β-catenin (Eq. 4.13) occurs when Wnt signaling is deactivated, which is
assumed to be the default state for this model (203). E-cadherin and β-catenin form a
cytoplasmic complex before localizing to the cytoplasmic membrane (Eq. 4.11), which
prevents both nuclear translocation as well as proteasomal degradation (70).
d[Ec]
dt
= −ai(t)[Ec] + di(t)[E/β], (4.10)
d[E/β]
dt
= ν(ET − [Ec]− [E/β])[β]− di(t)[E/β], (4.11)
d[β]
dt
= −ν(ET − [EC ]− [E/β])[β] + di(t)[E/β]︸ ︷︷ ︸
E-cadherin-β-catenin complex
− kf [β](PT − [C]) + kr[C]︸ ︷︷ ︸
Proteasomal complex
+km, (4.12)
d[C]
dt
= kf [β](PT − [C])− kr[C]− k2[C]. (4.13)
Rates for the β-catenin system (Eq. 4.10–4.13) are listed in Table 4.2. The total
proteasomal concentration in Eq. 4.12 and 4.13 is constant (PT=0.33514 nM), existing
only as either bound or unbound to β-catenin. Cytoplasmic E-cadherin, Ec, either
localizes to the membrane during cell-cell attachment, ai(t), or is freed from the
E-cadherin-β-catenin complex, [E/β], during cell-cell detachment, di(t).
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Parameter Symbol Value
Total E-cadherin concentration ET 100 nM
Total proteasome concentration PT 0.33514 nM
E-cadherin-β production rate ν 100 min−1
E-cadherin-β-catenin dissociation rate α 2 min−1
β-catenin proteasome binding rate kf 100 min
−1
β-catenin proteasome dissociation rate kr 100 min
−1
β-catenin degradation rate k2 0.03 min
−1
β-catenin production rate km 0.01 nM min
−1
E-cadherin membrane translocation rate ρ 200 min−1
Table 4.2:. Parameters and rates are shown for the β-catenin signaling system.
4.2.3 Cell-cell binding and unbinding
The attachment and detachment of cells with neighboring cells are defined by the
functions Eq. 4.14 and Eq. 4.15, respectively, where ρ is the E-cadherin membrane
translocation rate.
ai(t) =
∑
~x∈σ
ca,tρ (4.14)
di(t) =
∑
~x∈σ
cd,tρ (4.15)
The coupling functions, ca,t and cd,t give the difference in attachments and detachments
between a cell, σ, and its neighboring cells, σ′, in units of E-cadherin molecules per min.
The general form of the coupling function for the CPM is
ct+1 =
∑
~x∈{σ,σ′}
δ(σ~x, σ
′
~x)∑
σ~x
− ct, (4.16)
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in which the number of cell sites undergoing attachment and detachment are normalized
to the total number of cell-occupied lattice sites, σ~x. The Kronecker delta, δ, returns 1
when σ′~x 6= σ′~x and σ′~x 6= 0 and 0 otherwise
δ =

1 {~x ∈ σ′ : σ′~x 6= σ~x ∧ σ′~x 6= 0}
0 Otherwise
The von Neumann neighborhood, N vσ , gives the neighboring cell-occupied lattice
sites, σ′~x, within Manhattan distance r = 1 of cell σ (Eq. 4.17).
N vx0,y0 = {(x, y) : |x− x0|+ |y − y0| = r} (4.17)
Here, the set of perimeter lattice sites ~x0, ~y0 ⊂ σ~x have von Neumann neighbors ~x, ~y
(Fig. 4.4). Then simply take the difference in the number of all attachment sites of cell
σ for one Monte Carlo time step (scaling by 1 MCS = 4.8 minutes) and normalize to
the number of cell lattice sites, σ~x to find the concentration of bound E-cadherin dimers.
This assumes a uniformly distributed E-cadherin concentration over the cell membrane.
4.2.4 Mechanotransduction
The CPM previously described in Chapter 3 does not directly require cell-cell adhesion.
Rather, the distribution of traction forces within a multicellular cluster yields strains that
organize cell migration through mechanical cell-matrix feedback. As a result, cells tend
to migrate towards the centroid of the multicellular cluster as per Hdurotaxis (Eq. 3.5) yet
are prevented from overgrowing by the cell-cell contact energy, Jcc.
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Figure 4.4. (A) Cell σ (red squares) has the perimeter lattice site (x0, y0) with the von
Neumann contacts with cell σ′ (green squares) at (x+ 1, y) and (x, y − 1). (B)
Attachments and detachments occur when a cell extends or retracts, respectively, into a
vacant lattice site (grey squares).
Cell-cell junctions, however, maintain adhesion between neighboring cells in an
epithelial monolayer, and disruption requires either mechanical or chemical intervention.
For To capture mechanotransduction at the cell-cell adhesion, we use the junction force
predictions of the CPM as a regulator of cell attachment and detachment. Previously,
Ramis-Conde and colleagues applied a similar approach to predict the mobility of cells
within a monolayer (185). Given the length per contact and the adhesion energy per
unit length of contact, we can determine the energy of adhesion, or the anchorage force,
to maintain contact between two cells.
The anchorage force, described previously by Schaller & Meyer-Hermann (204), is
related to the contact area by
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F adij = Aijf
ad1
2
([R]i[L]j + [R]j[L]i), (4.18)
where Aij is contact area between cells i and j, and f
ad is the adhesive coefficient in units
of µN · µm−1. For our purposes, the receptor, R, and ligand, L, are both E-cadherin,
which acts as a homodimer, and thus Eq. 4.18 reduces to
F adij = Aijf
ad[E/β]i[E/β]j, (4.19)
where [E/β] is the E-cadherin-β-catenin complex from Eq. 4.11. The anchorage force
is therefore dependent on the E-cadherin-β-catenin complex concentration and contact
area between two cells. The contact area is the sum of contacting lattice sites described
in Eq. 4.16.
Ramis-Conde et al. (185) scale the adhesive coefficient fad by [E/β normalized to
total the E-cadherin concentration such that
% =
[E/β]
ET
%m, (4.20)
where %m = 200µN ·m−1 is the maximum adhesion strength coefficient and normalized
adhesion strength is on the interval [0 1]. Hence, using the junction force prediction
described in Chapter 3 and the anchorage force, we can determine the cell-cell bound
state, which is simply the Kronecker delta function
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δ(Jσ,σ′ , F
ad
σ,σ′) =

Bound, if Jσ,σ′ < F
ad
σ,σ′ ,
Unbound, Otherwise.
(4.21)
4.2.5 Signaling network coupling
The dynamical systems of Sections 4.2.1 and 4.2.2 provide the framework for the
molecular signaling pathway linking junction force to gene regulation. For molecular
transduction of junction force, β-catenin translocates to the nucleus after sufficient
accumulation in the cytoplasm, where it forms a DNA binding complex with TCF/LEF
to regulate transcription of EMT genes (205). Although, β-catenin regulation of the
EMT-associated GRN remains unclear, the Wnt/β-catenin signaling axis indirectly acts
on EMT-TFs SNAIL1 and ZEB. Wnt signaling stabilizes both SNAIL1 and β-catenin
through GSK3β inhibition (206), and TGF-β stimulates adherens junction disruption
thereby freeing β-catenin for nuclear translocation (207). As a result, Wnt/β-catenin
signaling regulate EMT in a similar fashion to TGF-β-induced EMT described by Tian
et al. (181).
For simplicity, Ramis-Conde et al. (185) assumes a critical threshold for β-catenin
activation of these transcriptional programs. Cytoplasmic [β] (Eq. 4.12) exceeding the
threshold cT =
1
2
[βmax] results in nuclear translocation. In effect, cT sets the cellular
sensitivity to undergo EMT. However, we substitute the cytosolic β-catenin for exogenous
TGF-β, [TGF0], as a perturbation to the EMT-GRN of the CBS model (Eq. 4.1 – 4.9).
Hence, disruption of cell-cell adhesion by mechanical force increases [β] (Eq. 4.12), which
in turn activates transcriptional regulation of the CBS model.
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CDH1 expression (Eq. 4.8) likewise provides feedback to the β-catenin signaling
network by adding to the cytoplasmic concentration of E-cadherin in Eq. 4.10, provided
the complete translation of mRNA to E-cadherin, and Eq. 4.8 becomes
d[Ec]
dt
= [Eg]− ai(t)[Ec] + di(t)[E/β], (4.22)
where [Eg] is the E-cadherin gene expression from Eq. 4.8. By nondimensionalization
of the E-cadherin concentrations from both systems (Sections 4.2.1 and 4.2.2) to
ET = 100 nM, the E-cadherin concentration bound in the membrane, available in the
cytoplasm, or bound to β-catenin are on the interval [0 1].
4.2.6 Phenotype characterization
From the gene expression described in Section 4.2.1, each cell has a distinct gene
expression profile from which we determine the phenotype. Using N-cadherin expression
as a marker of the mesenchymal phenotype (72) and normalizing to [Nmax], the
phenotype-specific property for each cell is mapped on the interval [0 1] in which 0 is
epithelial and 1 is mesenchymal. The simulated cell characteristics are listed in Table 4.3.
4.2.7 Numerical simulations
The CPM is initialized as previously described (Section 3.2.6). The gene profile is
initialized for each cell set to the epithelial phenotype and the corresponding phenotype-
specific properties. We numerically solve for the change in gene expression after each
Monte Carlo time step using the Runge-Kutta Fourth Order method with the conversion
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Parameter Symbol Epithelial Mesenchymal
Cell area A0 50.264 µm
2 240.005 µm 2
Proliferation probability %divide 0.005 0.0025
Cell-cell contact cost Jcc 2.5 5
Cell-matrix contact cost Jcm 2.5 1.25
Table 4.3:. The parameters shown are for the phenotype-specific properties used in the
CPM for Section 4.3.4
.
of 1 MCS ≈ 4.8 minutes (Section 3.3.2) and then to an in vitro timescale by 2
60
hour−1.
The phenotype is then determined from [N ]
[Nmax]
and cell-cell adhesion energy for each cell
pair from 4.20. The anchorage force for each cell-cell pair is compared with the junction
force to determine connectivity between multicellular clusters before determining the
force for the following time step.
For parameter analysis, the parameter set consisted of each phenotype-specific
property and phenotypes were assigned with a uniquely seeded random number on the
interval [0 1], and remained fixed for the duration of the simulation. The effects of each
property were qualitatively evaluated using the CPM map visualization (as shown in
Ch. 3) with a jet color mapping to identify the relative phenotypes.
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4.3 Results
4.3.1 Rate analysis
The phenotype for each cell is evaluated for each Monte Carlo step with a time step
equivalent to a single Monte Carlo step. We considered three numerical methods
for evaluating the change in expression of each gene expression profile. The built-in
MATLAB ODE solver (ode23s, MathWorks, Natick, MA) solves stiff, low order systems
of equations using an adaptive time step. We use this solution as an exact solution to the
integrated β-catenin signaling and EMT-associated GRN for comparison with the two
numerical solutions approximated by the Forward Euler and Runge-Kutta fourth-order
(Fig. 4.5).
The Forward Euler (Fig. 4.5 A, B) approximates changes in gene expression with
accuracy equivalent to the Runge-Kutta fourth-order (Fig. 4.5 C, D) for a time step h
of 4.8 minutes. E-cadherin expression (Fig. 4.5 A, C) closely approximates the ODE
solver for t < 9 days for both numerical methods, and N-cadherin closely approximates
for t < 6 days. For later time points, the percent error increases to nearly 50% during
the transition from the intermediate to mesenchymal phenotype between 8 to 14 days.
Decreasing the time step to h = 2.4 minutes reduces the percent error to less than 1%
for both numerical solutions.
4.3.2 EMT-associated gene expression
To identify spatiotemporal dynamics of phenotype progression within a heterogeneous
population of cells, we tracked the gene expression for each CPM cell throughout the
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Figure 4.5. The numerical solution (red line) approximates the analytical solution
(blue line). The numerical solution uses a time step of h = 4.8 minutes and the
analytical solution uses an adaptive time step set by the MATLAB ODE solver. The
E-cadherin gene expression (A,C) is shown for the Forward Euler solution (top row) and
the N-cadherin gene expression is shown for the Runge-Kutta fourth-order solution
(bottom).
simulation. Typically, E-cadherin and N-cadherin are the respective epithelial and
mesenchymal markers for delineating phenotype during EMT. Here, we used the relative
expression of N-cadherin to the maximum N-cadherin expression, [N ]
[Nmax]
, as an estimate
of mesenchymal transdifferentiation and assigned the phenotype cell characteristics as
discussed in 4.2.6. The gene expression of epithelial and mesenchymal markers was
averaged for all CPM cells at each time point in a single simulation as shown below
(Fig. 4.6).
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Figure 4.6. The temporal dynamics of gene expression of a heterogeneous cell
population reflects the relative phenotypes present. Endogenous TGF-β (A), E-cadherin
(B), and N-cadherin (C) expression averaged over the cell population are shown for a
single simulation. Concentrations are given in units of nM.
Prior to implementing β-catenin signaling dynamics, exogenous TGF-β acts as a
perturbation to the GRN. For simplicity, exogenous TGF-β concentration is maximal
([TGF0] = 3 nM , Table S2) when a cell has no contacting neighbors and 0 otherwise.
The endogeneous TGF-β concentration (Fig. 4.6 A) rapidly decreased to an expression
just below the initial concentration (Table 4.1) and stabilized for t > 50 MCS, suggesting
that the cells were not able to undergo EMT before reaching confluence. E-cadherin
expression (Fig. 4.6 B) decreased during the initial dynamic phase 0 < t < 200 MCS
accompanied by a reciprocal increase in N-cadherin expression (Fig. 4.6 C), likely owing
to the reduced cell-cell adhesion of the subconfluent monolayer previously observed in
Fig. 3.2. The expression of TGF-β, E-cadherin, and N-cadherin illustrate the relative
progression in phenotype for the entire cell population, from which we identify the
relative dynamics of EMT-associated events.
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4.3.3 β-catenin signaling
Previously, we substituted exogenous TGF-β for β-catenin signaling as a perturbation to
the EMT-associated GRN. However, β-catenin signaling regulates cell-cell adhesion by
either mechanically coupling the adherens junction to the actin cytoskeleton or through
nuclear translocation and suppression of the E-cadherin gene, CDH1. To capture the
effects of mechanotransduction on EMT, we first implement the Ramis-Conde β-catenin
signaling framework (185) with a dependence on cell-cell contact (Eq. 4.10–4.13). The
MATLAB ODE solution (ode45, MathWorks, Natick, MA) to this system is shown in
Fig. 4.7.
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Figure 4.7. Cell-cell adhesion regulates β-catenin signaling. Free β-catenin (blue line)
either forms a complex with cytoplasmic E-cadherin (purple line) or with a proteasome
(black line). E-cadherin is either localized at the cell-cell contact as the
E-cadherin-β-catenin complex or unbound in the cytoplasm (red line). The
concentration after 1 MCS is indicated at 4.8 minutes (circle). Values are normalized to
[E]max = 100 nM.
Figure 4.7 shows the concentrations of the four state parameters after cell-cell
contact at t = 0 minutes. Initially, β-catenin and E-cadherin are unbound in the
cytoplasm. The total E-cadherin concentration is conserved and either is unbound as
cytoplasmic E-cadherin or bound as a E-cadherin-β-catenin complex, which localizes at
the cell-cell contact to form an adherens junction. The proteasome is also conserved and
forms a complex with free β-catenin for polyubiquitination and degradation. E-cadherin-
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β-catenin complex formation has an initial toe region 0 < t < 0.25 minutes followed by a
region of linear growth 0.25 < t < 3 minutes before stabilizing at approximately 80 nM
for t > 6 minutes, which is limited by the availability of cytoplasmic E-cadherin. After
1 MCS the concentration of the E-cadherin-β-catenin complex is approximately 70% of
[E/β]max, which suggests an adherens junction bond strength of 1.40 × 10−4µN · µm−1
from Eq. 4.20. [E/β] < [E/β]max and thus % < %m without the production of additional
E-cadherin by the EMT-associated GRN. Rather than a static threshold for β-catenin
nuclear translocation and regulation of cell mobility, this β-catenin concentration
substitutes for the exogenous TGF-β perturbation to the EMT-associated GRN, which
has an intrinsic resistance to perturbation due to the miR-34 and miR-200 inhibitory
feedback (see Fig. 4.3).
4.3.4 Phenotype properties
A key result of the GRN is the effect of phenotype on cellular properties. Here, we
qualitatively show the effect of each phenotype-specific property described in Section 4.2.6
on the spatial distribution of a heterogeneous cell population (Fig. 4.8, S5 Video).
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Figure 4.8. The phenotype-specific properties of a heterogeneous cell population with
static phenotypes exhibit differential spatial patterning. Each phenotype property
shown refers to the values in Table 4.3.
Each cell property was varied independently of the others for 3, 000 MCS (10 days),
and each cell was randomly assigned an epithelial (0, blue cells) or mesenchymal (1,
red cells) phenotype, which remained unchanged throughout the simulation. The larger
cell area of the mesenchymal phenotype (Fig. 4.8 A) more frequently exceeds the
threshold area described in Section 3.2.5, which allows for rapid proliferation. As a
result, the mixed cell population rapidly reaches confluence before the subpopulations
are able to redistribute. The larger epithelial division probability (Fig. 4.8 B) forms
multicellular clusters surrounding the mesenchymal subpopulation, which then begin to
form embedded multicellular clusters. Similar to the effects of cell area, the division
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probability is restrictive to spatial redistribution of the subpopulations. Lastly, the
interaction energy (Fig. 4.8 C) produced epithelial spatial distributions visually similar
to that observed in Fig. 3.1 with self-organization of heterogeneous subpopulations.
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Discussion
The goal of this work was to develop a computational framework for evaluating the
mechanochemical regulation of the EMT program. In Chapters 2 and 3, we describe
an original, multiscale model integrating both molecular and cellular signaling with
physiologically relevant EMT-associated features. Expanding on previous computational
approaches, we introduced cell proliferation and collective cell dynamics to reproduce
EMT-associated cellular processes observed in vitro. We next used these junction force
predictions in regulation of cell-cell contacts, which are coupled to an intracellular
signaling cascade that targets the EMT-GRN. The gene expression of epithelial and
mesenchymal markers from this EMT-GRN then approximate the phenotype for each
cell, which then sets the phenotype-specific properties of those cells. One of the distinct
features of our computational approach is the ability to capture dynamics of EMT-
associated processes from the molecular to the tissue scale. This computational approach
provides a more thorough characterization of the previously unknown mechanical and
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chemical sequence of events, and in so doing lends itself to the elucidation of the
physiological and pathophysiological processes of the EMT program.
Chapter 3
In Chapter 3, we extended the van Oers model to account for cell proliferation and force
transduction about multicellular geometries. As a result, the CPM predicted spatial
distributions of intercellular tension as the second moment of area about the multicellular
cluster.
The CPM model demonstrates that traction forces scale with the size of the
multicellular cluster, a consequence of the FMA in which traction force is applied
at uniformly distributed cell-matrix adhesions (i.e., at all pixels in the CPM). A cell
cluster or monolayer may therefore regulate traction forces by varying the density or
distribution of cell-matrix adhesions, i.e. focal adhesions. The model further predicts
intercellular tension, by maintaining isometric tension throughout the monolayer,
which further regulates the distribution of cytoskeletal stress within a monolayer.
Our simulations predict that the intercellular tension nonlinearly decays with distance
from the monolayer centroid, which reflects the net distribution of cytoskeletal stress.
The observed differences between simulations and experiments may owe to the lack
of heterogeneity of phenotype-specific cellular properties, such as cell area and the
number of cell-cell and cell-matrix attachments. The FRET analysis of mammary breast
epithelium indicated junction force distribution depends on monolayer geometry and
not individual cell geometry, and the trends of our extended multicellular FMA model
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capture many key properties of monolayers undergoing EMT. Although the model poorly
reproduces spatial distribution trends observed in the control epithelial colony.
When coming into contact with other epithelial cells, migrating cells arrest growth
and form a cell-cell adhesion, which reduces the cell-cell contact inhibition. Disruption of
epithelial junctions results in redistribution of tension from the cell-cell junctions to the
cell-matrix attachments, thereby increasing mobility, growth, and spreading (194). By
TGF-β-induced EMT, cell area increases significantly in the periphery of the monolayer
accompanied by a slight decrease in intercellular tension relative to the interior of the
monolayer. This finding would seem to suggest a shift from cell-cell to cell-matrix
adhesion in the peripheral population. This attachment shift is reflected in the CPM
cell-cell and cell-matrix contact energies. By altering the cell-cell contact energy, the
CPM captures the effect of contact inhibition of neighboring cells in vitro. However,
in the CPM model, a defined target area partially constrains the simulated cell area
that, in turn, limits cell-matrix adhesion. The shift from cell-cell contact to cell-matrix
adhesion is indirectly restricted as a result. The spatial distribution of intercellular
tension therefore predicts the spatial distribution of cell area, which would seem to
indicate a shift towards cell-matrix adhesion.
Building on previous works that illustrate tensional homeostasis drives tissue
morphogenesis, these findings demonstrate that a gradient of intercellular tension forms
even in the absence of heterogeneous cell populations. Through transduction of the
mechanical gradient to molecular signaling pathways, tension distribution provides
positional information within a monolayer that regulates cellular phenomena such as
growth, proliferation, migration. This is of particular interest to spatially localized
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EMT-associated cellular processes, which corresponds with cell stress in the outer cell
population of the monolayer (162).
Although the various interaction energies reflect the resultant behavior of TGF-β-
induced EMT, differences observed in experimental and computational findings suggest
phenotype-specific properties are necessary to systematically reproduce spatiotemporal
dynamics of EMT. In Chapter 4, we explore the mechanochemical signaling interplay to
more accurately capture phenotype heterogeneity in an epithelial monolayer.
Chapter 4
In Chapter 4, we integrate an EMT-associated GRN and β-catenin signaling to capture
mechanical feedback at cell-cell junctions. The EMT-GRN regulates epithelial and
mesenchymal genetic markers E-cadherin and N-cadherin, and is sensitive to exogenous
TGF-β. The β-catenin signaling system transduces the intercellular tension across
cell-cell junctions to a molecular signaling pathway. To couple the two systems,
we substitute the exogenous TGF-β perturbation for the β-catenin concentration
and, likewise, introduce the EMT-GRN E-cadherin expression to the production of
cytoplasmic E-cadherin. By approximating the phenotype from N-cadherin expression,
we assign the phenotype-specific properties of cell area, proliferation rate, and contact
penalties for the CPM cells.
Coupling intercellular tension with downstream signaling captures a mechanically-
coupled gene regulatory network, which allows for tracking of unique phenotypes
and gene expression profiles for each cell in the simulation. This approach provides
two distinct advantages. Firstly, the initial loss of intercellular junctions permits a
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partial phenotypic state, indicative of an intermediate mesenchymal phenotype. Once
a confluent monolayer of epithelial cells form, and intercellular junctions form, cells
may revert back to an epithelial phenotype, which resembles rounds of EMT during
embryonic development. Secondly, after an epithelial sheet has formed, we can test
phenotype sensitivity of the epithelial sheet to parametric variations. We can additionally
determine if latent, intermediate phenotypes form without disrupting tissue homeostasis
at either subconfluence or confluence. An understanding of the interconnectivity between
mechanical and molecular stimuli will reveal critical signaling dynamics as potential
targets of anti-metastatic therapeutic strategies.
Conclusion
These findings offer insight into the coordinated induction of the EMT program by
mechanical and molecular stimuli, which are otherwise difficult to capture experimentally.
The key predictions presented in this work reveal critical intracellular signaling dynamics
necessary to understanding the pathophysiology of EMT-associated diseases. By
combining these approaches with extracellular feedback in future work, we will be able
to capture EMT events spanning molecular, cellular, and tissue scale dynamics, thereby
identifying the critical distinction in EMT as a healthy and an aberrant regulator of
tissue homeostasis.
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Limitations
Cellular Potts model
The finite element substrate described in Chapter 3 is a two-dimensional lattice with cell
attachments projected from the cell-occupied lattice site to its corresponding four nodes,
each node representing a separate attachment. This assumes discrete, linearly spaced
attachments and the cytoskeleton acts as a continuous structure. Furthermore, we
similarly consider a multicellular cluster to behave as a cohesive structure by requiring
the force transduction between cells to be linearly elastic. Therefore traction forces scale
in proportion to the linear distance from the centroid about the multicellular geometry.
In other words, traction force localizes to the cluster periphery. However, this may
only hold for an epithelial population in static equilibrium due to the high degree of
interconnection between neighboring cells (208).
Phenotype characterization
For monolayers containing subpopulation of cells with a high degree of individual cell
motility, the multicellular cluster transitions from static equilibrium to a dynamic tissue
- a process with similarities to EMT known as unjamming (209). This subpopulation
may migrate independently of the cluster despite maintaining cell-cell junctions.
One approach to address this issue is to set a phenotype-specific contractile strength
(µ, Eq. 3.12). By altering the peak traction force for a set area, partially differentiated
cells create preferential localized strains which reduce the local durotaxis Hamiltonian
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(Eq. 3.5) when moving away from the multicellular geometry, resulting in increased
mobility relative to the multicellular cluster.
Gene regulatory network
The deterministic EMT-GRN in Eqs. 4.1–4.9 and shown in Fig. 4.1 reproduces the gene
expression of key epithelial and mesenchymal gene markers E-cadherin and N-cadherin in
response to an applied perturbation by TGF-β. However, molecular signaling networks
are inherently stochastic. For the transcription factors, mRNA, miRNA, and EMT
genes characterized by Michaelis-Menten kinetics, the general rate equation for a double
negative feedback loop has the form
[A]− [B]→ [C]→ −[B], (5.1)
where [A] is the mRNA for transcription factor [C], and [B] is the miRNA. The miRNA
represses translation of [A] to [C], and likewise the transcription factor represses [B],
which yields increased translation of [C]. The production of [C] has rate k+ and
degradation of [C] has rate k−.
The ODE for Eq. 5.1 is given by
d[C]
dt
= k+
[A]
1 + [B]
J
n − k−[C], (5.2)
where the Michaelis-Menten constant, J, is for the species production rate and the Hill
coefficient, n, of species inhibition is equal for all species in the network. Applying the
white noise process ξ(t) to Eq. 5.2 yields
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d[C]
dt
= k+
[A]
1 + [B]
J
n − k−[C]︸ ︷︷ ︸
a(x,t)
+
σ√
∆t︸ ︷︷ ︸
b(x,t)
ξ(t), (5.3)
which is the stochastic differential equation (SDE) of the general ODE. The deterministic
term is denoted by a(x,t) and the stochastic term is denoted by b(x,t).
Next we apply the Euler-Maruyama method to approximate the numerical solution
of the general SDE in Eq. 5.3. The time discretization of the continuous stochastic
differential equation assumes
d[C]
dt
≈ ∆C
∆t
⇒ Cj+1 − Cj
∆t
(5.4)
and
ξ(t) =
∆B
∆t
≈ N(0, 1)√
∆t
, (5.5)
where ∆B is the Brownian motion process with mean 0 and variance 1. Substituting
Eq. 5.4 and Eq. 5.5 into Eq. 5.3 and solving for [C]j+1 yields the numerical solution
[C]j+1 = [C]j + (k
+ [A]j
1 +
[B]j
J
n − k−[C])∆t+ σ
√
∆tN(0, 1) (5.6)
for [C] at tj+1. This approach was applied to each ODE of the gene regulatory network
in Eq. 4.1–4.9 and the result is shown in S3 Figure.
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Future directions
Extracellular matrix, epithelial-mesenchymal transition, and
growth factor signaling
In addition to intercellular and subcellular signaling mechanisms, an extensive
extracellular signaling network also induces the same EMT-GRN discussed in Chapter 4
through mechanical and chemical stimuli. Previous computational models discussed in
Section 2.5 have illustrated the importance of molecular and mechanical feedback from
the extracellular matrix to drive EMT progression (176; 175; 177). The mechanism is
thought to heavily depend on TGF-β, which upregulates production of the mesenchymal
marker fibronectin (59). A latent form of TGF-β then binds to the growth factor-binding
domain of assembled fibronectin, concentrating TGF-β at the cell surface (60). Hence,
TGF-β is self-amplifying by stimulating fibronectin production and assembly.
To computationally reproduce this fibronectin and TGF-β positive feedback loop, a
similar approach taken by Daub & Merks (177) can be applied to model fibronectin and
TGF-β availability as either soluble, insoluble, or bound. The soluble form freely diffuses
from the source cell. In this way, each cell producing fibronectin and TGF-β creates a
localized chemotactic gradient. The insoluble fibronectin concentration requires both
cell contractility and soluble fibronectin for assembly. The bound TGF-β concentration
necessarily requires insoluble, unbound fibronectin, although soluble TGF-β is capable
of inducing EMT in the absence of fibronectin. The chemotactic gradient is then applied
to the CPM as a chemotactic Hamiltonian term, which reduces the cell-matrix contact
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energy for extensions lattice sites containing fibrillar fibronectin, bound TGF-β, or
soluble TGF-β.
This approach to modeling extracellular signaling feedback addresses the lack of an
ECM creation term in the Daub-Merks model. This presents two additional advantages
for implementation in a model of EMT. Firstly, ECM is closely regulated by the EMT
program. Secondly, ECM feedback induces phenotype-tailored cellular behavior by
sequestering growth factors at the cell surface and presenting mechanically distinct loci.
The assembled fibronectin and sequestered TGF-β at lattice domains presents an original
and adaptable chemotactic as well as haptotactic gradient for guiding cell migration.
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Supporting Information
Chapter 3
S1 Figure Connectivity of multicellular clusters. Simplified depiction of four
neighboring cells (gray) forming a multicellular cluster and the corresponding adjacency
matrix, A (left). Traction forces (red arrows) are proportional to the FMA about
the centroid of the cluster (green dot). Junction forces (blue arrows) balance the net
force imbalance for a given cell. The linear system is constructed from the mechanical
equilibrium matrix and junction symmetry matrix (right). The mechanical equilibrium
matrix is constructed from the connectivity of each cell given by the adjacency matrix
and by applying the force balancing principle. The junction symmetry matrix requires
each junction force across a cell-cell adhesion to be equal and opposite.
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S2 Figure Substrate strains of the single and multicellular FMA. Substrate
strains are shown for the FMA model of traction forces using the single cell geometry
(A) or multicellular geometry (B).
T1 Cellular Potts model and Finite element model parameters. Parameters
shown are for the CPM used in Chapters 3 and 4.
S1 Video. Single cell without proliferation. Simulated cell organization for the
single cell FMA model as shown in Figure 3.1A. Movie corresponds to simulation of 1000
Monte Carlo Steps.
S2 Video. Multicellular without proliferation. Simulated cell organization for
the multicellular FMA model as shown in Figure 3.1B. Movie corresponds to simulation
of 1000 Monte Carlo Steps.
S3 Video. In vitro proliferation. Spatiotemporal dynamics of MCF10A cells
confined to a 250 µm x 250 µm PDMS square as shown in Figure 3.2A. Movie corresponds
with experiments of 24 hours.
S4 Video. Multicellular CPM with proliferation. Spatiotemporal dynamics of
simulated cells for the multicellular FMA model with cell division probability of 0.5%
per time step as shown in Figure 3.2B. Movie corresponds to simulation of 1, 000 Monte
Carlo Steps.
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Chapter 4
S3 Figure EMT-associated gene regulatory network with stochastic
dynamics. The intermediate state is largely promoted by endogenous TGF-β expression
(Eq. 4.1), which is significantly diminished at steady state in the stochastic solution (S3
Figure). As the sole inhibitor of TGF-β translation, miR-200 (Eq. 4.6), and miRNAs
and mRNAs in general, are more sensitive to intrinsic noise due to low copy numbers.
This effect is also observed in zeb, snail, and miR-34 in the stochastic system. Thus, the
sensitivity of miRNA and mRNA to noise in the system likely diminished the endogenous
TGF-β expression, which in turn diminished the biphasic behavior of ZEB, and thus
regulation of E-cadherin and N-cadherin.
There are also significant limitations to the Euler-Maruyama method applied here
that could cause a loss of important dynamics. One limitation is the uniform time step
used to approximate a nonlinear Markov process. Dynamics in the toe regions of the
sigmoidal curves are particularly susceptible to noise due to the rapid rate of change
relative to the dynamics at other time points in the simulation. Simply reducing the
time step quickly becomes computationally expensive. A second limitation is that the
coupled differential equations have uncoupled noise and the copy number of mRNA and
miRNA is small when compared to the transcription factors and proteins.
One approach to address the time step limitation is to implement a τ -leap method
in which the time step is a Poisson distribution of the random variable. The update
procedure for Eq. 5.6 would be written as [C](t + τ) = [C]t +
∑
j∈M
vjKj + σ
√
∆tN(0, 1),
where K j is the Poisson distribution P (aj(X(t))τ with mean aj(X(t))τ and propensity
function for the jth reaction is ax(X(t)). The Poisson τ -leap thus updates each chemical
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reaction on the interval [t, t + τ) before moving to the next time step. A number from
the Poisson distribution is randomly generated on each time step, which gives inherent
noise to the system. The white noise term is retained to also simulate exogenous noise.
This is a computationally scalable approach for large stochastic systems.
Next, to address the noise sensitivity of low molecule numbers in the stochastic
approximation to a nonlinear Markov process, simply scale each molecule from
concentration to its number. Then randomly update the molecule number as an integer
for each reaction with the likelihood of an update dependent on the function propensity
function for that reaction. This method - known as the stochastic simulation algorithm,
or Gillespie algorithm - reflects the dynamics of cellular processes such that the change
of molecules is not tracked as a change in concentration, but rather the total number of
molecules in a cell.
Combining the Poisson τ -leap method and the Gillespie algorithm accounts for the
internal stochasticity while reducing the computational limitations of small fixed time
steps. Although some genetic networks may demonstrate a reduced sensitivity to noise
in a cellular process, the stochastic system, when given in the complete context of gene
regulation of spatiotemporally dynamic processes such as EMT, may produce phenotypes
that otherwise would be difficult to capture experimentally or in a deterministic system.
This is particularly true in dealing with gene regulatory networks consisting of many
pleiotropic genes.
T2 EMT-associated gene regulatory network parameters and rates.
Parameters and rates are shown for the EMT-associated gene regulatory network used
in Chapter 4.
98
6. SUPPORTING INFORMATION
S5 Video. Single cell without proliferation. Simulated cell organization for the
phenotype-specific cell area as shown in Figure 4.8A. Movie corresponds to simulation of
3, 000 Monte Carlo Steps.
S6 Video. Single cell without proliferation. Simulated cell organization for the
phenotype-specific division probability as shown in Figure 4.8B. Movie corresponds to
simulation of 3, 000 Monte Carlo Steps.
S7 Video. Single cell without proliferation. Simulated cell organization for the
phenotype-specific interaction energy as shown in Figure 4.8C. Movie corresponds to
simulation of 3, 000 Monte Carlo Steps.
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Supplemental material for
“Mechanochemical Regulation of Epithelial Tissue
Remodeling: A Multiscale Computational Model of
the Epithelial-Mesenchymal Transition Program”
Supporting Figures
Figure S1. Connectivity of multicellular clusters.
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Figure S2. Substrate strains of the single and multicellular FMA.
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Figure S3. EMT-associated gene regulatory network with stochastic dynamics
evaluated at 3 nM exogenous TGF-β stimulation for 18.75 simulation days. The
deterministic solution (solid blue line) indicates an intermediate steady state. The
stochastic solution (red dashed line) shows a loss of the intermediate state as the result
of noise of the low molecule number for mRNA and miRNA-200.
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Supporting Tables
Parameter Symbol Value
Element size ∆x 2.5 µm
Intrinsic cell motility T 1
Target cell area A0 314.16 µm
2
Proliferation area minimum Adivide 209.44 µm
2
Proliferation probability Pdivide 0.005
Elasticity parameter λarea 500
Cell-matrix contact cost Jcm 2.5* pixels/side
Cell-cell contact cost Jcc 5.0* pixels/side
Young’s modulus E 10 kPa
Poisson’s ratio ν 0.45
Traction force constant µ 0.01 nN/µm
Table S1:. Cellular Potts model and Finite element model parameters. * Value used
unless otherwise noted.
Parameter Symbol Value
Exogenous TGF-β T0 3.0 nM
Basal TGF-β production rate k0T 0.06 µM hr
−1
TGF-β production rate kT 1.2 µm hr
−1
miR200-dependent inhibition of TGF-β expression JT 0.06 µM
TGF-β degradation rate kdT 0.6 hr
−1
Basal snail1 transcription rate k0s 0.0006 µM hr
−1
snail1 transcription rate ks 0.003 µM hr
−1
TGF-β-dependent snail1 translation rate Js 1.6 µM
snail1 mRNA degradation rate kds 0.09 hr
−1
snail1 mRNA translation rate kS 16 µM hr
−1
miR-34-dependent inhibition of snail1 translation JS 0.08 µM
Degradation rate of SNAIL1 kdS 1.66 hr
−1
Basal miR− 34 production rate k03 0.0012 µM hr−1
miR-34 production rate k3 0.012 µM hr
−1
SNAIL1-dependent inhibition of miR-34 production J13 0.15 µM
ZEB-dependent inhibition of miR-34 production J23 0.36 µM
miR-34 degradation rate kd3 0.035 hr
−1
Basal zeb transcription rate k0Z µM hr
−1
zeb transcription rate kz µM hr
−1
Continued on the next page
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Table S2 – continued from previous page
SNAIL1-dependent zeb transcription Jz µM
zeb mRNA degradation rate kdz hr
−1
zeb translation rate kZ 17 µM hr
−1
miR-34-dependent inhibition of zeb mRNA translation JZ 0.06 µM hr
−1
ZEB degradation rate kdZ 1.66 hr
−1
Basal miR-200 production rate k02 0.0002 µM hr
−1
miR-200 production rate k2 0.012 µM hr
−1
SNAIL1-dependent inhibition of miR-200 production J12 5 µM
ZEB-dependent inhibition of miR-200 production J22 0.2 µM
miR-200 degradation rate kd2 0.035 hr
−1
E-cadherin production rate 1 ke1 1 µM hr
−1
E-cadherin production rate 2 ke2 0.6 µM hr
−1
SNAIL1-dependent inhibition of E-cadherin production Je1 0.2 µM
ZEB-dependent inhibition of E-cadherin production Je2 0.5 µM
E-cadherin degradation rate kde 0.5 hr
−1
N-cadherin production rate 1 kn1 1 µM hr
−1
N-cadherin production rate 2 kn2 0.6 µM hr
−1
SNAIL1-dependent inhibition of N-cadherin production Jn1 0.2 µM
ZEB-dependent inhibition of N-cadherin production Jn2 0.5 µM
N-cadherin degradation rate kdn 0.5 hr
−1
TGF-β-dependent SNAIL1 expression nnt 2
SNAIL1-dependent activation or inhibition nns 2
ZEB-dependent inhibition nnz 2
miR-200-dependent inhibition nnr2 2
miR-34-dependent inhibition nnr3 2
Table S2:. EMT-associated gene regulatory network parameters and rates.
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